In mouse, early stages of paraxial mesoderm development can be recapitulated *in vitro* by first inducing an epiblast fate with Activin A/FGF, followed by culture with the Wnt agonist CHIRON99021(Chir) and the BMP inhibitor LDN193189 (LDN) (CL medium)^[@R4],[@R6]^ ([Fig. 1a](#F1){ref-type="fig"}, [Extended data Fig. 1a](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"}). After 24 hours in CL medium, epiblast-like cells acquire a neuromesodermal progenitor (NMPs)^[@R7],[@R8]^/anterior primitive streak (aPS) fate, expressing *T/Brachyury, Sox2* and *Pou5f1 (Oct4)*([Fig 1a](#F1){ref-type="fig"}, [Extended data Fig. 1b](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"}). By 48 hours, cells activate the PSM markers *Tbx6* and *Msgn1* ([Fig. 1a](#F1){ref-type="fig"}, [Extended data Fig. 1b](#F5){ref-type="fig"}--[e](#F5){ref-type="fig"}). This transition to PSM is paralleled by an epithelium-to-mesenchyme transition (EMT) marked by a switch from *Cdh1* to *Cdh2* ([Extended Data Fig. 1b](#F5){ref-type="fig"}).

To further characterize the identity of these mouse PSM cells generated *in vitro*, we benchmarked their transcriptomes against the embryonic mouse PSM. Using single cell RNA-sequencing (scRNA-seq)^[@R9]^, we analyzed 5,646 cells dissociated from the posterior region of two E9.5 mouse embryos. Clustering analysis revealed 21 distinct cell states corresponding to expected derivatives of all three germ layers ([Extended Data Fig. 2a](#F6){ref-type="fig"}--[d](#F6){ref-type="fig"} and [Table S1](#SD2){ref-type="supplementary-material"}). Transcriptomes of paraxial mesoderm and neural tube cells, which share a common developmental origin^[@R7],[@R10]^, were represented as a k-nearest neighbor (kNN) graph ([Fig. 2a](#F2){ref-type="fig"}). Genes differentially expressed between cell clusters ([Extended Data Fig 3a](#F7){ref-type="fig"}--[d](#F7){ref-type="fig"}) and along a pseudo-temporal trajectory ([Fig. 2b](#F2){ref-type="fig"} and [Table S2](#SD3){ref-type="supplementary-material"}) stratified distinct phases of paraxial mesoderm differentiation as follows: One cluster, co-expressing *Sox2* and T/*Brachyury*, represented neuromesodermal progenitors (NMPs) and was positioned between the posterior neural tube and paraxial mesoderm clusters, consistent with the known bipotentiality of these cells^[@R7]^. Two clusters expressing *T, Rspo3, Tbx6, Dll3*, and *Foxc1*, represented mesodermal precursor cells (MPCs)^[@R11]^and the more mature posterior PSM (pPSM), respectively. These two clusters express Notch pathway genes *Hes7, Lfng, Dll1*, and *Dll3* ([Extended Data Fig 3c](#F7){ref-type="fig"}--[e](#F7){ref-type="fig"}) and likely correspond to the *in vivo* oscillatory domain. The next cluster corresponds to the anterior PSM (aPSM) marked by *Mesp2* and *Ripply2* ([Fig 2b](#F2){ref-type="fig"}).

We compared the transcriptomes of these E9.5 *in vivo* mouse cell states to those of 21,478 mouse ESCs differentiated *in vitro*. Clustering analyses indicated rapid mESC differentiation over the first three days, with each timepoint largely dominated by a single cluster: naïve ESCs (Day 0), epiblast (Day 2), and NMPs (Day 3), followed by asynchronous transcriptional changes over the final two days ([Fig 2c](#F2){ref-type="fig"}, [Extended Data Fig 3f](#F7){ref-type="fig"}--[g](#F7){ref-type="fig"}). A substantial proportion of the differentiating mESC adopted a similar fate trajectory as the cells *in vivo*, progressively expressing *Sox2, T, Rspo3, Tbx6, Dll3*, and *Foxc1* ([Fig 2d](#F2){ref-type="fig"}, [Extended Data Fig 3h](#F7){ref-type="fig"}--[j](#F7){ref-type="fig"}). Approximately 46% of differentiating mESCs ultimately adopted a pPSM-like state ([Fig 2c](#F2){ref-type="fig"}, [Extended Data Fig 3h](#F7){ref-type="fig"}). We trained a kNN-classifier on the transcriptional signatures of mouse E9.5 clusters and used it to assign identities to individual d4/5 mESC-derived cells. An E9.5 pPSM-like identity was the most abundantly classified state within cells of the d4/5 mESC 'pPSM' cluster ([Fig 2g](#F2){ref-type="fig"}). E9.5-pPSM-classified states were enriched amongst the pPSM branch of d4/5 mESC kNN graph ([Fig 2h](#F2){ref-type="fig"}), and similar enrichments were observed for three classification algorithms ([Extended Data Fig 4a](#F8){ref-type="fig"}). Strikingly, we also detected a collinear trend in Hox genes expression during mESC differentiation ([Extended Data Fig 4b](#F8){ref-type="fig"}). Together, these results suggest broad transcriptional similarity between mESC-derived paraxial mesoderm cells and their *in vivo* counterparts.

Oscillations of a *Hes7-Luciferase* reporter in PSM cells differentiated from mouse ESCs in 3D cultures have been recently reported ^[@R12]^. To visualize oscillations of the segmentation clock in 2D, we generated an mESC reporter line where a destabilized version of the YFP variant Achilles was knocked in the 3' end of the mouse *Hes7* gene^[@R13]^ ([Extended data Fig. 1g](#F5){ref-type="fig"}). When differentiated towards PSM, a subset of cells showed oscillatory *Hes7-Achilles* expression with a period of 2.5 ± 0.4 hours (n=25), similar to the period of the segmentation clock in mouse embryos^[@R14],[@R15]^ ([Fig. 1b](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}, [Extended data Fig. 1h](#F5){ref-type="fig"}--[i](#F5){ref-type="fig"}, [Video S1](#SD4){ref-type="supplementary-material"}). This oscillatory state could be extended by adding Fgf4, the RA inhibitor BMS493 and the Rho kinase inhibitor (ROCKi) Y-27362 to CL medium (CLFBR medium) (CL 45 ± 6.6 hours, n=8 vs. CLFBR 61.2 ± 5.7 hours, n=12; [Extended data Fig. 1j](#F5){ref-type="fig"}--[k](#F5){ref-type="fig"}). Therefore, PSM cells differentiated from ESCs *in vitro* can reliably model the segmentation clock.

We next implemented a similar *in vitro* strategy to identify the human oscillator. Human iPSCs differentiated in CL medium acquire an NMP/aPS fate characterized by *T/BRACHYURY* and *SOX2* expression after 24 hours ([Fig. 1a](#F1){ref-type="fig"}), and a PSM fate marked by *MSGN1* and *TBX6* expression after 48 hours ([Fig. 1a](#F1){ref-type="fig"}, [Extended data Fig. 1f](#F5){ref-type="fig"}). A CDH1 to CDH2 switch is observed as in mouse ESCs ([Extended data Fig. 1b](#F5){ref-type="fig"}). The induction efficiency of human cells carrying a *MSGN1-Venus* knock-in reporter was remarkably high compared to mouse, reaching 92.6 ± 1.5% (n=8) ([Extended data Fig. 1d](#F5){ref-type="fig"}--[e](#F5){ref-type="fig"}, [Video S2](#SD5){ref-type="supplementary-material"}).

We compared 14,750 differentiating human iPSCs analyzed by scRNA-seq to *in vivo* and *in vitro* mouse cell states. Early collection timepoints clustered uniformly and sequentially along the kNN graph, whereas the final two timepoints displayed continuous and overlapping transcriptional features ([Extended Data Fig. 3k](#F7){ref-type="fig"}--[l](#F7){ref-type="fig"}). Differential gene expression and pseudo-temporal ordering analyses revealed shared molecular characteristics between the human clusters and both the *in vivo* and *in vitro* mouse PSM lineages ([Fig 2e](#F2){ref-type="fig"}--[f](#F2){ref-type="fig"}, [Extended Data Fig. 3m](#F7){ref-type="fig"}--[o](#F7){ref-type="fig"}). Cells collected after 1 day exhibited characteristics of NMPs/aPS with expression of *NODAL, T, MIXL1* and *SOX2*. Day 2 human cells resembled the mouse MPC and posterior PSM clusters with expression of *T, MSGN1, TBX6, DLL3, WNT3A* and *FGF17*, as well as the Notch-associated cyclic genes *LFNG* and *HES7*. Day 3/4 cells show expression of markers of anterior PSM such as *FOXC1* ([Fig. 2f](#F2){ref-type="fig"}, [Extended data Fig 3l](#F7){ref-type="fig"}). Machine learning classifiers trained on the mouse embryonic cell states consistently assigned an E9.5-pPSM-like identity to the day 2-4 human iPSC clusters ([Figure 2g](#F2){ref-type="fig"}--[h](#F2){ref-type="fig"}, [Extended Data Fig. 4c](#F8){ref-type="fig"}). We detected collinear activation of HOX gene clusters, beginning with *HOXA1* and *HOXA3* on day 1 and culminating with *HOXB9* and *HOXC8* on day 4 ([Extended Data Fig. 4d](#F8){ref-type="fig"}). Thus, differentiating human iPSCs to a PSM fate *in vitro* in CL medium recapitulates a developmental sequence similar to that of the mouse embryo leading to the production of trunk paraxial mesoderm cells.

To assess whether human iPSC-derived PSM cells exhibit segmentation clock oscillations, we generated a *HES7-Achilles* iPSC reporter cell line ([Extended data Fig. 1g](#F5){ref-type="fig"}). After 48 hours in CL medium, most cells started to show reporter oscillations with a mean period of 4.9 ±0.3 hours (n=25) and constant frequency ([Fig. 1c](#F1){ref-type="fig"}, [e](#F1){ref-type="fig"}--[f](#F1){ref-type="fig"}, [Extended data Fig. 1l](#F5){ref-type="fig"}--[p](#F5){ref-type="fig"}, [Videos S3](#SD6){ref-type="supplementary-material"}--[4](#SD7){ref-type="supplementary-material"}). No oscillations could be detected when LDN was omitted, consistent with the need for BMP4 inhibition to induce the paraxial mesoderm fate([Extended data Fig. 1q](#F5){ref-type="fig"})^[@R16]^. The total number of oscillations observed could be approximately doubled by culturing in CLFBR medium (CL 4.7 ±0.8 vs. CLFBR 10.2 ±1.6 oscillations, n=15; [Extended data Fig. 1r](#F5){ref-type="fig"}--[s](#F5){ref-type="fig"}). These experiments support the existence of a human segmentation clock ticking with a \~5-hour period.

A characteristic property of the segmentation clock oscillations *in vivo* is their high local synchrony^[@R1]--[@R2]^. Synchronization of oscillations appears recapitulated *in vitro* in human but not mouse PSM cells ([Fig. 1d](#F1){ref-type="fig"},[f](#F1){ref-type="fig"}). To track individual human iPSC-derived PSM cells, we diluted *HES7-Achilles* cells expressing a nuclear label (*pCAG-H2B-mCherry)* in an excess of unlabeled cells ([Fig. 3a](#F3){ref-type="fig"}, [Extended data Fig. 5a](#F9){ref-type="fig"}, [Video S5](#SD8){ref-type="supplementary-material"}). The average diffusion of cells *in vitro* (2.4±2.2 μm^2^/min; [Extended data Fig. 5b](#F9){ref-type="fig"}) was comparable to that of chicken embryo PSM cells *in vivo* (0.5-8 μm^2^/min)^[@R19]^. Analysis of the phase of individual oscillators did not reveal any spatial structure, arguing against the existence of traveling waves in these cultures ([Extended data Fig. 5c](#F9){ref-type="fig"}; [Video S6](#SD9){ref-type="supplementary-material"}). Tracking large numbers of cells allowed us to assess quantitatively the degree of global synchrony using the Kuramoto order parameter^[@R17]^. This analysis confirmed that cells oscillate in synchrony, as the order parameter was significantly higher relative to a model with randomized phases (0.43 ±0.15 vs. 0.094±0.09, p\<0.000001, n=139 cells; [Fig. 3b](#F3){ref-type="fig"}--[c](#F3){ref-type="fig"}; [Extended data Fig. 5d](#F9){ref-type="fig"}--[f](#F9){ref-type="fig"}).

The Kuramoto order parameter decreased over time, indicating a progressive decay of synchrony ([Fig. 3c](#F3){ref-type="fig"}, [Extended data Fig. 5d](#F9){ref-type="fig"},[f](#F9){ref-type="fig"}). This prompted us to explore cell division as a potential source of increasing noise over time. Cell division was not temporally coordinated between cells, with roughly 5% of cells in M phase at any given point ([Extended data Fig. 5g](#F9){ref-type="fig"}--[h](#F9){ref-type="fig"}). The cell cycle time was 22 ±3.6 hours (n=26), indicating that division takes place on a different time scale than *HES7* oscillations ([Extended data Fig. 5i](#F9){ref-type="fig"}). The ratio between cell division time and clock period is the same as observed *in vivo* for chicken PSM^[@R18],[@R19]^. Distribution of phases at mitosis was evenly spread, suggesting a lack of correlation between the phase of *HES7-Achilles* oscillations and cell division ([Extended data Fig. 5j](#F9){ref-type="fig"}). Inhibiting cell division with Aphidicolin ([Extended data Fig. 5h](#F9){ref-type="fig"}), did not affect oscillations or order parameter dynamics (Control 0.404 ±0.2065, n=45 vs. Aphidicolin 0.3465 ±0.1526, n=48, p=0.348; [Extended data Fig. 5k](#F9){ref-type="fig"}--[m](#F9){ref-type="fig"}). Thus, cell division is not a significant source of noise for *HES7-Achilles* oscillations in human PSM cells *in vitro*.

Notch signaling has been implicated in maintenance and local synchronization of oscillations^[@R5],[@R20]--[@R22]^. Treatment of human and mouse *HES7-Achilles* cells with the Notch inhibitor DAPT in CLFBR medium led to a dampening of oscillations ([Fig. 3d](#F3){ref-type="fig"}--[e](#F3){ref-type="fig"}; [Extended data Fig. 5n](#F9){ref-type="fig"}--[p](#F9){ref-type="fig"}). Thus, *HES7* oscillations require active Notch signaling. The Kuramoto order parameter was lower and decreased more rapidly in DAPT-treated cultures relative to control (Control 0.407 ±0.22, n=131 vs. DAPT 0.266 ±0.153, n=110, p\<0.000001; [Fig. 3f](#F3){ref-type="fig"}, [Extended data Fig. 5q](#F9){ref-type="fig"}). We conclude that synchronization of *HES7* oscillations in human iPS-derived PSM cultures is Notch-dependent.

We further assessed whether YAP signaling regulates oscillations in human cells as in mouse embryos^[@R5]^. No oscillations were detected when human PSM cells were cultured as isolated cells, ([Fig. 3g](#F3){ref-type="fig"}--[h](#F3){ref-type="fig"}, [Video S7](#SD10){ref-type="supplementary-material"}). However, treatment with Latrunculin A (LatA), which inhibits YAP signaling^[@R23]^, restored oscillations ([Fig. 3h](#F3){ref-type="fig"}; [Extended data Fig. 5r](#F9){ref-type="fig"}; [Video S7](#SD10){ref-type="supplementary-material"}). Isolated cells treated with LatA continued to oscillate even with DAPT treatment ([Fig. 3h](#F3){ref-type="fig"}, [Video S7](#SD10){ref-type="supplementary-material"}). We could not detect significant enrichment of NOTCH1 intracellular domain binding at the *HES7* or *LFNG* promoters in isolated cells by ChIP-qPCR ([Extended data Fig. 5s](#F9){ref-type="fig"}). Isolated cells treated with LatA alone or in combination with DAPT showed the characteristic \~5-hour period observed in confluent cultures, arguing that period is controlled autonomously, independently of Notch cleavage ([Extended data Fig. 5u](#F9){ref-type="fig"}). The Kuramoto order parameter was significantly lower than in confluent controls (control 0.415 ±0.194, n=53 vs. LatA 0.221 ±0.137, n=18 vs. LatA+DAPT 0.1972 ±0.095, n=18), arguing that cell communication is required for maintenance of synchrony ([Extended data Fig. 5v](#F9){ref-type="fig"}--[w](#F9){ref-type="fig"}). Thus, the human segmentation clock, like its mouse counterpart^[@R4]^, can be viewed as an excitable system where Notch provides the stimulus and YAP controls the excitability threshold.

*In vivo*, PSM cells experience posterior-to-anterior gradients of FGF and Wnt signaling that control their maturation ([Fig. 4a](#F4){ref-type="fig"}). In differentiating mouse and human cultures, staining for dpERK and β-catenin showed that the FGF and Wnt pathways are active at the NMP and pPSM stages but strongly downregulated at later stages in CL medium ([Fig. 4a](#F4){ref-type="fig"}). Treatment with the FGF receptor inhibitor PD173074 (PD17) decreased the dpERK signal ([Extended data Fig. 6a](#F10){ref-type="fig"}), indicating that ERK activation is FGF-dependent and most likely downstream of FGF8 and FGF17, which are expressed by the cells ([Extended data Fig. 6b](#F10){ref-type="fig"}). Thus, differentiating mouse and human cells are exposed to transient Wnt/FGF signaling as in the posterior PSM *in vivo* ([Fig. 4a](#F4){ref-type="fig"}). The regulation of FGF and Wnt signaling *in vitro* is largely autonomous.

We next assessed the effect of prematurely downregulating FGF and Wnt signaling on segmentation clock oscillations *in vitro*. FGF signaling was inhibited by treating human PSM cells with PD17 or the MEK1/2 inhibitor PD0325901 (PD03), whereas Wnt signaling was blocked using the tankyrase inhibitors XAV939 or IWR-1 ([Extended data Fig. 6c](#F10){ref-type="fig"}--[e](#F10){ref-type="fig"}). Both FGF and Wnt inhibition resulted in dampening and delayed arrest of oscillations without affecting their period ([Fig. 4b](#F4){ref-type="fig"}--[c](#F4){ref-type="fig"}, [Extended data Fig. 6f](#F10){ref-type="fig"}--[h](#F10){ref-type="fig"}). In the case of PD03, higher doses resulted in faster dampening and fewer oscillations before arrest ([Fig. 4d](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"}, [Extended data Fig. 6i](#F10){ref-type="fig"}--[l](#F10){ref-type="fig"}). Mouse *Hes7-Achilles* cells responded similarly to FGF and Wnt inhibitors ([Extended data Fig. 6m](#F10){ref-type="fig"}). Intriguingly, oscillations in human cells treated with FGF inhibitors but not Wnt inhibitors exhibited a phase-shift relative to control cells, regardless of inhibitor dosage ([Fig. 4f](#F4){ref-type="fig"}, [Extended data Fig. 6n](#F10){ref-type="fig"}--[o](#F10){ref-type="fig"}). We could also detect this phase shift in Notch target gene oscillations upon FGF inhibition by time-lapse qRT-PCR for the *HES7* and *LFNG* genes ([Extended data Fig. 6p](#F10){ref-type="fig"}--[q](#F10){ref-type="fig"}). These data suggest that FGF functions to modulate oscillator properties in addition to controlling PSM maturation.

To further examine the role of FGF signaling on oscillatory properties, we used an *ex-vivo* system consisting of micropatterned cultures of PSM explants taken from the mouse line *LuVeLu* (a *Lunatic fringe* transcriptional reporter)^[@R5]^ ([Extended data Fig. 6r](#F10){ref-type="fig"}). Treating mouse cultures with increasing doses of FGF inhibitors led to a dose-dependent decrease in number of oscillations ([Extended data Fig. 6s](#F10){ref-type="fig"}--[t](#F10){ref-type="fig"}). We observed a progressive increase in period with increasing inhibitor doses, as observed for *Lfng* oscillations during PSM maturation *in vivo*^[@R14]^([Extended data Fig. 6u](#F10){ref-type="fig"}). Our data thus indicate that FGF activity regulates the dynamics (i.e. period, phase and amplitude) of cyclic gene oscillations and does not only control the oscillatory arrest at the wavefront as proposed in classical models^[@R1],[@R24]^.

*In vivo*, cells at the determination front periodically activate *Mesp2* and *Ripply2* in a stripe defining the boundaries of the future segment^[@R25]^. By qPCR, we observed that arrest of *HES7-Achilles* oscillations in human cells coincided with *MESP2* and *RIPPLY2* expression, which could be delayed by culturing cells in CLFBR medium ([Extended data Fig. 1f](#F5){ref-type="fig"},[s](#F5){ref-type="fig"}). To image the transition from the oscillatory to the segmental fate, we generated a dual human iPSC reporter line carrying a knock-in *MESP2-H2B-mCherry* reporter in addition to *HES7-Achilles*. When cultured in CLFBR medium, a series of approximately 12 oscillations were followed by activation of the *MESP2-mCherry* signal in an increasing subpopulation of scattered cells ([Fig. 4g](#F4){ref-type="fig"}; [Extended data Fig. 7a](#F11){ref-type="fig"}--[b](#F11){ref-type="fig"}, [Video S8](#SD11){ref-type="supplementary-material"}). Treatment with the Notch inhibitor DAPT prevented *MESP2-mCherry* activation, as expected given that *Mesp2* is a Notch target in mouse embryos ([Extended data Fig. 7c](#F11){ref-type="fig"}; [Video S8](#SD11){ref-type="supplementary-material"}). Conversely, oscillatory arrest and *MESP2-mCherry* onset was prematurely triggered by either FGF or Wnt inhibition ([Fig. 4h](#F4){ref-type="fig"}--[I](#F4){ref-type="fig"}; [Extended data Fig. 7a](#F11){ref-type="fig"}--[b](#F11){ref-type="fig"}, [d](#F11){ref-type="fig"}--[e](#F11){ref-type="fig"}; [Video S8](#SD11){ref-type="supplementary-material"}). Increasing concentrations of PD03 resulted in faster activation of *MESP2* ([Extended data Fig. 7b](#F11){ref-type="fig"}). Therefore, human iPSC-derived PSM cells recapitulate segmental determination, which is dynamically controlled by FGF and Wnt levels.

Our work provides evidence for the existence of a human segmentation clock demonstrating the conservation of this oscillator from fish to human. We identify the human clock period as \~5 hours, indicating that it operates roughly 2 times slower than its mouse counterpart^[@R14]^. This is consistent with the known difference in developmental timing between mouse and human embryos ^[@R26]^. Our culture conditions wherein cells are treated with only two chemical compounds in defined medium allow the production of an unlimited supply of human PSM-like cells. This therefore represents an ideal system to dissect the dynamical properties of the oscillator and its dysregulation in pathological segmentation defects such as congenital scoliosis.

METHODS {#S1}
=======

Generation of reporter lines {#S2}
----------------------------

The CRISPR/Cas9 system for genome editing^[@R27]^ was used to generate three reporter lines in human iPSCS (*HES7-Achilles, HES7-Achilles; pCAG-H2B-mCherry*, and *HES7-Achilles; MESP2-mCherry*) and one mouse ESC reporter line (*Hes7-Achilles*). To target the *HES7* locus in human NCRM1 iPS cells, a single guide RNA ([Extended data Table 1](#T1){ref-type="table"}) targeting the 3' end of *HES7* was designed using the MIT Crispr Design Tool ([www.crispr.mit.edu](http://www.crispr.mit.edu)) and cloned into the pGuide-it-tdTomato vector (Takara cat. no. 632604). We also generated a repair vector consisting of 1kb 3' and 5' homology arms flanking a self-cleaving T2A peptide sequence, followed by the fast-folding YFP variant Achilles^[@R16]^, two destabilization domains (CL1 and PEST), and a nuclear localization signal (T2A-Achilles-NLS-CL1-PEST) in a pUC19 vector backbone by means of Gibson assembly (NEB). The assembled repair vector was then mutated by site directed mutagenesis to eliminate the PAM site (specific mutation noted in [Extended data Table 1](#T1){ref-type="table"}) in using the In-Fusion cloning kit (Takara). Both the pGuide-it-tdTomato and targeting vectors were delivered to iPS cells by nucleofection using a NEPA 21 electroporator. 24 hours after nucleofection, cells were sorted by TdTomato expression using an S3 cell sorter (Biorad) and seeded at low density in Matrigel-coated plates (Corning, cat. no. 35277) in mTeSR1 (Stemcell Technologies cat. no. 05851) + 10μM Y-27362 dihydrochloride (Tocris Bioscience, cat. no. 1254). Single cells were allowed to expand clonally and individual colonies were screened by PCR for targeted homozygous insertion of 2A-Achilles-CL1-PEST-NLS immediately before the stop codon of *HES7*. Positive clones were sequenced to ensure no undesired mutations in the *HES7* locus had been introduced by the genome editing process. Three homozygous clones were further validated by qRT-PCR and immunofluorescence.

An identical approach was used to target the *Hes7* locus in mouse E14 ESCs, except the pGuide-it-tdTomato and targeting vectors were delivered by lipofection using Lipofectamine 3000 (Invitrogen cat. no. L3000001). Following sorting, TdTomato+ cells were seeded at low density on gelatin-coated dishes (EMD Millipore cat. no. es-006-b) in 2i medium (see below). Individual colonies were then transferred to a 96 well plate for expansion. Once ready to passage, the master plate was split onto three different 96 well plates. One plate was used for genotyping and the other two were frozen. Positive clones were then thawed, expanded, and had their genotype confirmed by PCR and sequencing. Only one clone carrying the targeted homozygous insertion of 2A-Achilles-CL1-PEST-NLS in the *Hes7* locus was found and further characterized.

To generate the double reporter line *HES7-Achilles; MESP2-mCherry*, we co-transfected the pGuide-it-tdTomato vector containing a single guide RNA targeting the 3' end of the *MESP2* coding sequence ([Extended data Table 1](#T1){ref-type="table"}), and a targeting vector composed of 1kb homology arms flanking a T2A-H2B-mCherry sequence in the pUC19 backbone, in NCRM1 *HES7-Achilles* cells by nucleofection (Amaxa). We sorted, expanded, genotyped and sequenced individual clones as described above. Three independent instances of successful homozygous insertion were found.

To insert the constitutively expressed pCAG-H2B-mCherry reporter in the safe harbor *AAVS1* locus in NCRM1 *HES7-Achilles* cells, we used the approach previously described by Oceguera-Yanez and colleagues^[@R28]^. Briefly, we cloned the H2B-mCherry sequence into the pAAVS1-P-CAG-DEST vector (Addgene) by Gibson assembly and co-transfected it along with the pXAT2 vector (Addgene) into *HES7-Achilles* cells. Two days after nucleofection, we selected positive clones by supplementing mTeSR1 with puromycin (0.5 μg/mL, Sigma--Aldrich cat. no. P7255) for a total of 10 days. We obtained two positive clones and confirmed the homozygous insertion of H2B-mCherry by PCR.

Mouse ESC cell culture and 2D differentiation {#S3}
---------------------------------------------

E14 mouse ESCs were maintained under feeder-free conditions in gelatin-coated dishes with 2i medium composed of high glucose DMEM (Gibco cat. no. 11965-118) supplemented with 1% GlutaMAX (Gibco cat. no. 35050061), 1% Non-Essential Amino Acids (Gibco cat. no. 11140-050), 1% Sodium Pyruvate (Gibco cat. no. 11360-070), 0.01% Bovine Serum Albumin (Gibco cat. no. 15260-037), 0.1% β-mercaptoethanol (Gibco cat. no. 21985-023), 15% Fetal Bovine Serum (EMD Millipore cat. no. ES009B), 1000 U/mL LIF (EMD Millipore cat. no. ESG1106), 3μM CHIR99021 (Sigma Aldrich cat. no. SML1046) and 1μM PD0325901 (Stemgent cat. no. 04-006). mESCs were passaged by TryplE (Gibco cat. no. 12605010) dissociation every two days at a density of 1× 10^4^ cells per cm^2^. Paraxial mesoderm differentiation was carried out as previously described ^[@R19]^, with small modifications. mESCs were seeded at a density of 1× 10^4^ cells per cm^2^ in fibronectin-coated dishes (BD Biosciences cat. no. 356008) in N2B27 medium (StemCell Technologies cat. no. 07156 and 05731) supplemented with 25 ng/ml Activin A (R&D systems cat. no. 338-AC-050) and 12 ng/ml bFGF (PeproTech cat. no. 450-33). After 48 hours in culture, the differentiation medium was changed to high glucose DMEM (Gibco cat. no. 11965-118) supplemented with 1% GlutaMAX (Gibco cat. no. 35050061), 1% Non-Essential Amino Acids (Gibco cat. no. 11140-050), 1% Sodium Pyruvate (Gibco cat. no. 11360-070), 0.01% Bovine Serum Albumin (Gibco cat. no. 15260-037), 0.1% β-mercaptoethanol (Gibco cat. no. 21985-023), 15% Fetal Bovine Serum (EMD Millipore cat. no. ES009B), 3μM CHIR99021 (Sigma Aldrich cat. no. SML1046) and 0.5 μM LDN193189 (Stemgent cat. no. 04-0074). Cells were cultured for four additional days and medium was changed daily. For live imaging experiments, cells were seeded on 24 well glass-bottom plates (In Vitro Scientific cat. no. P24-1.5H-N) on day 0 and cultured in DMEM without phenol red (Gibco cat. no. 31053028) from day 4 onwards. To extend the time spent in the oscillatory state, we additionally supplemented the differentiation medium with 50 ng/ml mFgf4 (R&D Systems cat. no. 5846-F4-025), 1 μg/ml Heparin (Sigma Aldrich cat. no. H3393-100KU), 2.5 μM BMS493 (Sigma Aldrich cat. no. B6688-5MG) and 10 μM Y-27362 dihydrochloride (CLFBR medium^[@R4]^) from day 4 onwards.

Human iPS cell culture and 2D differentiation {#S4}
---------------------------------------------

Human stem cell work was approved by Partners Human Research Committee (Protocol Number 2017P000438/PHS). We complied with all relevant ethical regulations. Written informed consent from the donor of the NCRM1 iPS cells was obtained by Rutgers University at the time of sample collection. NCRM1 iPS cells (RUCDR, Rutgers University) and lines carrying the *MSGN1-Venus*^[@R19]^ or *HES7-Achilles/HES7-Achilles; pCAG-H2B-mCherry/ HES7-Achilles; MESP2-mCherry* reporters were maintained in Matrigel-coated plates (Corning, cat. no. 35277) in mTeSR1 medium (Stemcell Technologies cat. no. 05851) as previously described^[@R9]^. Paraxial mesoderm differentiation was carried out as described^[@R9]^. Briefly, mature iPS cell cultures were dissociated in Accutase (Corning cat. no. 25058CI) and seeded at a density of 3 × 10^4^ cells per cm^2^ on Matrigel-coated plates in mTeSR1 and 10μM Y-27362 dihydrochloride (Rocki; Tocris Bioscience, cat. no. 1254). Cells were cultured for 24-48 hours until small, compact colonies were formed. Differentiation was initiated by switching to CL medium consisting of DMEM/F12 GlutaMAX (Gibco cat. no. 10565042) supplemented with 1% Insulin-Transferrin-Selenium (Gibco cat. no. 41400045), 3 μM Chir 99021 (Tocris cat. no. 4423) and 0.5 μM LDN193189 (Stemgent cat. no. 04-0074). On day 3 of differentiation, cells were changed to CLF medium consisting of CL medium with 20ng/ml murine bFGF (PeproTech cat. no. 450-33). Media was changed daily.

For live imaging experiments, differentiation was performed as described above, except cells were seeded on 35 mm matrigel-coated glass-bottom dishes (MatTek cat. no. P35G-1.5-20-C) or 24 well glass-bottom plates (In Vitro Scientific cat. no. P24-1.5H-N). DMEM/F12 without phenol red was used to reduce background fluorescence (Gibco cat. no. 21041025 ).

To extend the oscillatory window of differentiated PSM cells, we cultured *HES7-Achilles* cells in CLFBR medium consisting of DMEM/F12 GlutaMAX, 1% ITS, 3 μM Chir 99021, 0.5 μM LDN193189, 50 ng/ml mFgf4 (R&D Systems cat. no. 5846-F4-025), 1 μg/ml Heparin (Sigma Aldrich cat. no. H3393-100KU), 2.5 μM BMS493 (Sigma Aldrich cat. no. B6688-5MG) and 10 μM Y-27362 dihydrochloride starting on day 2 of differentiation^[@R4]^. Media was refreshed daily.

To automatically track oscillations in individual cells within the culture, we mixed *HES7-Achilles; pCAG-H2B-mCherry* cells with NCRM1 cells in a ratio of 1:100 at the time of seeding for pre-differentiation. Cells were then differentiated normally under CLFBR conditions.

To examine oscillations in isolated cells, we differentiated *HES7-Achilles* cells normally (CL medium) for the first two days on 35mm plastic dishes and dissociated them with Accutase (Corning cat. no. 25058CI) on day 2 of the differentiation protocol. Cells were reseeded on fibronectin-coated (BD Biosciences cat. no. 356008) or bovine serum albumin (BSA)-coated (Gibco cat. no. 15260-037) 24 well glass-bottom plates at high (500,000 cells per well) or low density (25,000-50,000 cells per well) in CLFBR media. Using our regular DMEM/F12 base media resulted in poor survival of low density cultures. We found that using RHB Basal media (Takara/Clontech cat. no. Y40000), supplemented with 5% knockout serum replacement (KSR; Thermo Fisher cat. no. 10828-028) improved survival significantly.

Explant culture {#S5}
---------------

Explant culture was performed as previously described^[@R4]^. *LuVeLu* CD1 E9.5 mice (both male and female) were sacrificed according to local regulations in agreement with national and international guidelines. We complied with all relevant ethical regulations. Study protocol was approved by Brigham and Women's Hospital IACUC/CCM (Protocol number N000478). Sample size was not estimated, nor were randomization or blinding performed. Tailbud was dissected with a tungsten needle and ectoderm was removed using Accutase (Life Technologies). Explants were then cultured on fibronectin-coated plate (LabTek chamber). The medium consists of DMEM, 4.5g/L Glucose, 2mM L-Glutamine, non-essential amino acids 1x (Life Technologies), Penicillin 100U/mL, Streptomycin 100μg/mL, 15% fetal bovine serum (FBS), Chir-99021 3μM, LDN193189 200nM, BMS-493 2.5 μM, mFgf4 50ng/mL, heparin 1μg/mL, HEPES 10mM and Y-27632 10μM. Explants were incubated at 37°C, 7.5% CO2. Live imaging was performed on a confocal microscope Zeiss LSM 780, using a 20X objective (note that the tiling could create lines between the different images). For micropattern culture, explants were cultured overnight in standard condition, then dissociated using Trypsin-EDTA, and plated on fibronectin-coated CYTOOchips Arena in a CYTOOchamber 4 wells.

Small Molecule Inhibitor Treatments {#S6}
-----------------------------------

To inhibit Notch signaling, 25 μM DAPT (Sigma Aldrich cat. no. D5942-5MG) was added to CLFBR media on day 2 of differentiation. To inhibit FGF signaling, PD0325901 (Stemgent 04-006) or PD173074 (Cayman Chemical cat. no. 219580-11-7) were added to CL or CLFBR media at the indicated concentrations. Wnt signaling was inhibited with the tankyrase inhibitors XAV939 (Sigma Aldrich cat. no. X3004) and IWR-1 (Sigma Aldrich cat. no. I0161) at 2μM and 12μM, respectively, in CLFBR medium. Cell division was blocked by arresting cells at early S phase with 5μM Aphidicolin (Sigma Aldrich cat. no. A0781) in CLFBR medium. Cells were pre-treated for 24 hours with Aphidicolin prior to imaging (during day 2). The onset of imaging was thus delayed by one day and started only on day 3. Aphidicolin was maintained in the medium throughout imaging. Latrunculin A (Cayman Chemical ca. no. 10010630), which inhibits actin polymerization and YAP signaling, was used at 350 nM in RHB basal media supplemented with CLFBR and 5% KSR. Mouse explants and micropatterned cultures were treated with PD0325901 (Sigma- concentration as described in the text) and PD173074 (Sigma - 250nM).

Time-lapse Microscopy {#S7}
---------------------

Time lapse-imaging of PSM cells was performed on a Zeiss LSM 780 point-scanning confocal inverted microscope fitted with a large temperature incubation chamber and a CO~2~ module. An Argon laser at 514 nm and 7.5% power was used to excite the Achilles fluorophore through a 20X Plan Apo (N.A. 0.8) objective, whereas a DPSS 561 laser at 561nm and 2% laser power was used to excite mCherry samples. Images were acquired with an interval of 18 minutes in the case of human samples and 4.5 minutes for mouse samples, for a total of 24-48 hours. A 3x3 tile of 800x800 pixels per tile with a single z-slice of 18 μm thickness and 12-bit resolution was acquired per position. Multiple positions, with at least two positions per sample, were imaged simultaneously using a motorized stage. Explant imaging was performed on a Zeiss LSM780 microscope using a 20X/0.8 objective. For mouse cells imaging, single section (\~19.6μm wide) with tiling (3x3) of a 512x512 pixels field was acquired every 7.5 minutes (in most experiments) at 8-bit resolution.

Immunostaining {#S8}
--------------

For immunostaining of 2D cultures, cells were grown on Matrigel-coated glass-bottom plates or 12mm glass coverslips placed inside plastic dishes or, alternatively, on 24 well glass-bottom plates (In Vitro Scientific cat. no. P24-1.5H-N). Cells were rinsed in Dulbecco's phosphate buffered saline (DPBS) and fixed in a 4% paraformaldehyde solution (Electron Microscopy Sciences cat. no. 15710) for 20 minutes at room temperature, then washed 3 times with phosphate buffered saline (PBS). Typically, samples were permeabilized by washing three times for three minutes each in Tris buffered saline (TBS) with 0.1% Tween (known as TBST) and blocked for one hour at room temperature in TBS-0.1% Triton-3% FBS. Primary antibodies were diluted in blocking solution and incubated overnight at 4⁰C with gentle rocking. Primary antibodies and dilution factors are listed in [Ext. Data Table 2](#T2){ref-type="table"}. Following three TBST washes and a short 10-minute block, cells were incubated with Alexa-Fluor conjugated secondary antibodies (1:500) and Hoechst33342 (1:1000) overnight at 4⁰C with gentle rocking. Three final TBST washes and a PBS rinse were performed, and cells were mounted in Fluoromount G (Southern Biotech cat. no. 0100-01). Images were acquired using either a Zeiss LSM880 or LSM780 point scanning confocal microscope with a 20X objective.

For visualizing phospho-ERK1/2 in 2D monolayer differentiated cells, cells were transferred onto ice and quickly rinsed in ice-cold PBS containing 1 mM sodium vanadate (NaVO~4~). Next, cells were fixed in 4% paraformaldehyde for 15 min at room temperature, rinsed three times in PBS and dehydrated in cold methanol at −20⁰C for 10 minutes. Following three PBS rinses, cells were blocked in PBS containing 0.1% Triton X-100 and 5% goat serum and incubated in pERK1/2 antibody diluted in antibody buffer (0.1% Triton X-100 and 1% BSA in PBS) overnight at 4⁰C. Cells were washed in PBS, and incubated in blocking solution for 10 minutes and with secondary antibody and Hoechst33342 in antibody buffer overnight at 4⁰C. Cells were rinsed three times in PBS before mounting and imaging as described above.

RNA extraction, reverse transcription and qPCR {#S9}
----------------------------------------------

Cells were harvested in Trizol (Life Technologies cat. no. 15596-018), followed by precipitation with Chloroform and Ethanol and transferred onto Purelink RNA Micro Kit columns (Thermo Fisher cat. no. 12183016) according to manufacturer's protocol, including on-column DNase treatment. A volume of 22 μl RNase-free water was used for elution and RNA concentration and quality were assessed with a Nanodrop. Typically, between 0.2-1 μg of RNA was reverse transcribed using Superscript III First Strand Synthesis kit (Life Technologies cat. no. 18080-051) and oligo-dT primers to generate cDNA libraries.

For real time quantitative PCR, cDNA was diluted 1:30 in water and qPCR was performed using the iTaq Universal SYBR Green kit (Bio-Rad cat. no. 1725124). Each gene-specific primer and sample mix was run in triple replicates. Each 10 μl reaction contained 5 μl 2X SYBR Green Master Mix, 0.4 μl of 10 μM primer stock (1:1 mix of forward and reverse primers), and 4.6 μl of diluted cDNA. qPCR plates were run on a Bio-Rad CFX384 thermocycler with the following cycling parameters: initial denaturation step (95°C for 1 minute), 40 cycles of amplification and SYBR green signal detection (denaturation at 95°C for 5 seconds, annealing/extension and plate read at 60°C for 40 seconds), followed by final rounds of gradient annealing from 65°C to 95°C to generate dissociation curves. Primer sequences are listed in [Extended Data Table 3](#T3){ref-type="table"}. All unpublished primers were validated by checking for specificity (single peak in melting curve) and linearity of amplification (serially diluted cDNA samples). For relative gene expression analysis, the ΔΔCt method was implemented with the CFX Manager software. *PP1A* was used as the housekeeping gene in human iPSC samples, whereas *Actb* was used in mouse ESC samples. Target gene expression is expressed as fold change relative to undifferentiated iPS/ESC cells.

Flow Cytometry Analysis {#S10}
-----------------------

To determine the fraction of PSM cells *expressing pMsgn1-Venus*/*MSGN1-Venus*, cultures were dissociated in Accutase and analyzed by flow cytometry using an S3 cell sorter (Biorad). Undifferentiated ESCs or iPS cells, which do not express the fluorescent protein, were used as a negative control for gating purposes. Samples were analyzed in biological triplicates. Results are presented as the percentage of Venus positive cells in the sorted fraction.

Chromatin Immunoprecipitation (ChIP)-qPCR {#S11}
-----------------------------------------

Binding of NOTCH1 to the promoters of *ACTB, LNFG* and *HES7* was analyzed by ChIP. Cells were crosslinked for 30 minutes using ChIP Cross-link Gold reagent (Diagenode, C01019027), rinsed with PBS and then 1% formaldehyde for 15 minutes. After quenching with 125μM glycine and rinsing the crosslinked cells with ice-cold PBS, cells were harvested using a cell scraper. Cell lysis and pulldown of chromatin with A/G protein coated magnetic beads was performed on approximately 300 thousand cells per immunoprecipitation using MAGnify™ ChIP kit (ThermoFisher cat. no. 492024) following manufacturer's instructions. Chromatin fragmentation was performed using a Covaris M220 sonicator for 5 minutes (75 watts PIP, 5% DF and 200 cycles/burst). NOTCH1 immunoprecipitation was performed using 3.3 μg of anti-NOTCH1 (D1E11, 3608S Cell Signaling) per immunoprecipitation. This antibody binds the transactivation domain of NOTCH1 and has been successfully used for ChIP-seq applications in the past^[@R29]^. 0.5 μg of anti-Acetyl-Histone H3 (Lys9) (C5B11, 9649S Cell Signal) was used. Fold enrichment (2^−ΔCt^) was calculated relative to isotype IgG controls, immunoprecipitated with 3.3 μg of normal rabbit IgG (2729S Cell Signal). Enriched loci after ChIP were interrogated by qPCR using primers designed to amplify \~100bp surrounding previously identified RBPJ binding sites in the *HES7* and *LFNG* promoters^[@R30],[@R31]^.

Image Analysis {#S12}
--------------

Time lapse movies of *HES7-Achilles* were first stitched and separated into subsets by position in the Zen program (Zeiss). Then, background subtraction and Gaussian blur filtering were performed in Fiji^[@R32]^ to enhance image quality. When single cell tracking was not performed, a small region of interest (ROI) was drawn and the mean fluorescence intensity over time was calculated. Intensity is presented in arbitrary units. When appropriate, the moving average was subtracted with window size of 3 hours for human PSM (i.e. 10 timepoints) and mouse PSM (i.e. 40 timepoints), and then normalized between 0 and 1. For smoothening, we applied the Sgolay filtering function in MATLAB.

Following moving average subtraction, we performed Fourier transformation of *HES7-Achilles* intensity profiles to determine the predominant period of oscillations. The Hilbert transformation was used to calculate the instantaneous frequency and phase of *HES7-Achilles* oscillations from ROIs. To compare the phase between ROIs in DMSO and PD17 or PD03 treated cultures, we used the Hilbert transformation to calculate the instantaneous phase of each curve separately, then subtracted the phase of treated cells from untreated cells at each timepoint. Phase difference is expressed as the average of instantaneous phase differences before the arrest of oscillations in treated cells.

To manually track oscillations in mouse ESC-derived PSM cells as well as isolated or sparse human *HES7-Achilles* cells in a NCRM1 background, we tracked cells by drawing a circle around the nucleus of an individual cell at each time point and measuring fluorescence intensity inside the ROI. To remove saturated pixels corresponding to autofluorescent debris in mESC-PSM movies, we set pixels with intensity \>700 a.u. (above dynamical range of *mHes7-Achilles*) to background level (=100 a.u.) in MATLAB. In the case of *hMESP2-mCherry*, we established a threshold for activation (25 a.u.) by taking the mean of several ROIs representing the background noise.

For mouse explants, kymographs were done in Fiji^[@R32]^ by drawing a rectangle from the starting center of the traveling waves to the edge of the explant perpendicular to the direction of the wave. The intensity along the long axis was measured and the image was smoothened (this filter replaces each pixel with the average of its 3 × 3 neighborhood).

Fluorescence intensity profiles were done by selecting a circular region of interest in Fiji^[@R32]^ and by measuring the total intensity over time for this region; *LuVeLu* intensity is given in arbitrary units (normalized by the initial value) and a smoothing function (average over three points) was applied. Fluorescence intensity shows the mean fluorescence smoothed by applying a moving average over five points (with equal weight). For the quantification of micropattern experiments, a region of interest encompassing the entire surface of one circle was drawn and the *LuVeLu* intensity was measured using the Time Series Analyzer V3 plugin on Fiji^[@R32]^. The period was measured by measuring the time between two peaks or two troughs. The average intensity was measured by averaging the intensity over 3 hours to avoid instantaneous variations dues to the oscillations.

Automatic image segmentation and cell tracking {#S13}
----------------------------------------------

Cells were automatically segmented and tracked on the microscopy movies using a custom algorithm. To this end, we first identified and listed the cell positions and cell shapes using a detection of the connected components of a thresholded image applied to the *pCAG-H2B-mCherr*y channel (using the *bwconncomp* Matlab algorithm). For reliability, we used a minimal denoising based on morphological operations (*imopen* then *imclose* functions of Matlab, both with radius 1px). The shape of the cell was used to detect the level of expression of *HES7-Achilles* by considering the average *HES7-Achilles* level within the connected component detected in the *pCAG-H2B-mCherry* channel. This provides us with a list of cell positions together with the associated average *HES7-Achilles* intensity, for each frame of the microscopy movie.

Tracks were then reconstructed consecutively by finding, given a cell in frame k, the closest cell in frame k+1 within a distance of 20 μm, consistent with the typical movement of a cell between two frames, and not too large to avoid switching tracks. This provided us with cells tracks, that trajectories of the cells in the microscopy field. By matching these tracks with the recorded *HES7-Achilles* intensity, we thus obtained *HES7-Achilles* activity as a function of time for each single cell tracked by the algorithm.

Phase analysis {#S14}
--------------

While collective oscillations appear very regular, *HES7-Achilles* expression in single cells shows heterogeneous profiles and fluctuating background fluorescence intensity (see [Video S5](#SD8){ref-type="supplementary-material"}), and phase detection requires specific attention^[@R33]^. To derive accurately a phase of oscillation for a single cell, we used a custom method based on Hilbert transform ([Method 1](#S15){ref-type="sec"}), and two control methods providing very similar results ([Methods 2](#S16){ref-type="sec"} and [3](#S17){ref-type="sec"}). We relied on [Method 1](#S15){ref-type="sec"} for the main figures as it provided an accurate estimate even during the first periods of the oscillations.

### Method 1: Hilbert transform; {#S15}

The Hilbert transform is a functional transform of time series whose argument provides an efficient estimate of the phase of a signal (and its modulus, the envelope amplitude). Hilbert transforms are quite sensitive to drifts in the signals and changes in the shape of the oscillation. Classically, Hilbert transform follows a detrending pre-processing based on removing a linear drift. To improve the evaluation of the phase using the Hilbert transform in the present case where drifts are nonlinear and amplitudes vary in time, we used a local renormalization algorithm, similar to^[@R33]^, consisting in (i) centering locally the signal using a moving average computed over a time window of 6h around the current time point (Matlab function *movmean*, 6 hours providing a duration slightly larger than the period of the average signal), allowing correcting for local changes in the average signal, and (ii) normalizing the amplitude dividing the centered signal by a sliding standard deviation, computed on the same window of 6h (Matlab function *movstd*). We then evaluated the phase using the *hilbert* function of Matlab.

### Method 2: Cross-correlations; {#S16}

We also developed a methodology for evaluating phase shifts between two signals S1(t) and S2(t) based on a local cross-correlations estimate. In detail, at a given time *t*, the algorithm finds the delay *dt* between 0 and 4h maximizing the correlation between the chunk of signal S1(*s*) and S2(*s+dt*) over the time interval *s $\in$ \[t,t+6h\]*. We developed this algorithm using a custom Matlab code and used this algorithm to compute phase differences between pairs of cells.

### Method 3: {#S17}

A third method used for control was developed based on detecting peaks of the signals. In detail, we detected the times at which the signal peaks using the *findpeaks* function of Matlab. When peaks are detected at times t~0~, t~1~, ..., t~n~, the phase of the signal at a given time t ∈ \[t~i~, t~i+1~\] was defined as the relative fraction of time between between the two consecutive peaks, $\phi = \frac{t - t_{i}}{t_{i + 1} - t_{i}}$. *findpeaks* was also used to count the number of oscillations before arrest at the single cell level.

Synchronization {#S18}
---------------

To quantify the level of synchrony between the *HES7-Achilles* expression in multiple cells, we first selected tracks that were followed for multiple periods of oscillations (minimal duration of 15hours and Fourier transform larger than a lower threshold - the selection using Fourier transform did not significantly modify the statistics). Next, we computed the Kuramoto order parameter, also known as vector strength^[@R20],[@R34]^ of a given set of signals phases. Considering n signals with phases *θ*~1~, .., *θ~n~*, the Kuramoto order parameter Z is defined by $$\text{Z} = \frac{1}{\text{n}}{\sum\limits_{\text{j} = 1}^{\text{n}}\text{e}^{\text{i}\text{θ}_{\text{j}}}}$$ where i is the complex variable. This provides a complex number whose angle corresponds to the average phase and whose modulus (norm) quantifies the level of synchrony. The modulus of Z is indeed equal to 1 when all oscillators have the same phase (in which case Z = e^i*θ*^ where *θ* is the common phase of all oscillators), and it is equal to 0 when the phases are uniformly spread between 0 and 2*π*. For uniformly distributed phases with standard deviation equal to *σ*, the amplitude of the Kuramoto order parameter is equal to $\frac{sin\left( \sigma \right)}{\sigma}$, a function smoothly decaying from 1 to 0 as *σ* goes from 0 to *π*.

Using the phases we derived for each track, we evaluated as a function of time the order parameter and its modulus. Of course, because of natural experimental fluctuations and the finite number of cells considered, asynchronous cells are characterized by a low, but non-zero, Kuramoto order parameter. To assess whether the observed Kuramoto order parameter was statistically consistent with synchrony, we evaluated what would be the level of Kuramoto order parameter norm for asynchronous sets of cells. To this end, we used our evaluated phases *θ*~1~(*t*), .., *θ~n~*(*t*) and constructed multiple surrogate datasets by shuffling the phase relationships between those trajectories, but preserving their intrinsic frequency of oscillations. To this end, we drew time-shifts uniformly in \[0,T\] where T is the total time considered for the phases, for each cell. This yields n times *τ*~1~, .., *τ~n~*, from which we derived the Kuramoto order parameter for a set of phases *θ*~1~(*t* + *τ*~1~), .., *θ~n~*(*t* + *τ~n~*), wrapped on the interval \[0,T\], i.e. times t+*τ~i~* are taken modulo T, and computed the associated order parameter. We repeated this randomization 1000 times and obtained a stable distribution of the Kuramoto order parameter for phases with no specific phase relationship. This provided a level of Kuramoto order parameter consistent with asynchrony. We then tested whether the order parameter found for the original data was consistent with synchrony by comparing this value to the distribution of surrogate order parameters.

Spatio-temporal wave {#S19}
--------------------

To assess whether the data were organized into a spatio-temporal wave pattern, we used our extensive dataset containing both the instantaneous positions and instantaneous phases for the cells that were detected by our automatic segmentation and tracking algorithm. For each pair of cells, we computed their instantaneous (physical) distance as well as their phase-shift. This provided us with a very large dataset, that we organized according to ranges of distances, chosen so that each set contained approximately the same number of cell pairs (distance less than 160μm, between 160 and 265 μm, between 265μm and 530μm, and larger than 530μm - the number of cells at a distance larger than 530μm was not kept equal to the other numbers to keep sufficient resolution). We then plotted the distribution of phase shifts for each distance class, and used the 2-sample Kolmogorov-Smirnov test (Matlab function *kstest2*) to compare two-by-two, these distributions (we took care of the classical sample-size bias of the test by selecting large subsets of equal size for each distance class^[@R35]^), and obtained a p-value for whether the two samples were drawn from the same distribution or not. We consistently found that the distribution of phase shifts was not dependent on the distance between cells.

Diffusion coefficient {#S20}
---------------------

To characterize cellular movement from automated cell tracks and test the hypothesis that the cells movement was consistent with freely diffusing particles (Brownian motion), we computed the mean square displacement of each cell in an automatically identified track a given time lag. In detail, the mean square displacement is defined by: $\Delta_{\tau}^{k} = < \left\| {x_{t + \tau}^{k} - x_{t}^{k}} \right\|^{2} >_{t}$ where k is a tracked cell label, t is time, and the angular bracket indicate that an average on all possible t is taken (i.e., if track k lasts up to time T~k~, the average is taken for ∈ {1, .., *T~k~* − *τ*} ). Freely moving cells with diffusivity *D* should have a linear mean squared displacement $\Delta_{\tau}^{k} = 4D\tau$. By fitting a linear curve to the mean square displacement for all cells, we obtained an estimate for D as well as a p-value for assessing the validity of the linear fit (ANOVA).

Period of oscillations {#S21}
----------------------

The period of oscillations in automatically tracked cells was computed using fast Fourier transform (Matlab function *fft*) of the centered *HES7-Achilles* expression for each cell tracked (the centering consisted only of removing the mean value of the signal in time). Peaks of the Fourier transforms were identified using the *findpeaks* Matlab function, and the most prominent peak was used to compute the period of the signal. To confirm this estimate of the period, we used an alternative method based on identifying the peaks in *HES7-Achilles* expression for each cell and computing the difference between the times of the peaks. We found a very good agreement between the two methods.

Phase Shifts {#S22}
------------

To assess the relative phase shift between two samples at the single cell level (e.g. control vs. PD03), we first obtained the phases as a function of time for each automatically tracked cell as described above. We then calculated the phase difference between all possible pairs of cells between the two samples at all timepoints and displayed these data in histograms. We additionally computed the mean phase shift across all timepoints for all pairs of cells and the corresponding standard deviation. To compare the phase shift between different pairs of samples, we used non-parametric one-way ANOVA with the Kruskal--Wallis test.

Cell Division Analysis {#S23}
----------------------

Our automated cell tracking algorithm (described above) did not detect cell division, but rather selected one daughter cell at random and continued tracking without interruption. Thus, we resorted to manual tracking for the detection of cell division. We used the Fiji^[@R32]^ plugin ManualTracks and recorded the timepoints at which cells underwent mitosis. Manual tracking was performed on the *pCAG-H2B-mCherry* channel, such that chromatin compaction during cell division was clearly identifiable and tracks were completely independent from *HES7-Achilles* intensity. Cell division time was defined as the time elapsed between the time a cell first divides and the time one of its daughter cells divides again. Once cell division events were manually identified, we used an automatic tracking to recover the tracks before and after cell division. In detail, given a cell division event at time t and at a given location of the field, we identified in our automatically identified cell the closest match. When the distance between the automatically and manually identified cells was small enough (here, below 21 μm distance), we recovered the *HES7-Achilles* expression from the associated already identified track. If there was no cell identified near the manually identified location (in some rare cases, manually identified dividing cells had not been detected by the algorithm), we used locally a version of the automatic tracking algorithm (in a sub-image of 5.3x5.3μm) to derive a cell location and an associated *HES7-Achilles* expression. This data was then processed exactly as the automatically identified tracks, and we obtained the phases of the oscillations of the dividing cells. We then built the histogram of the phases at cell division, and used the one-sample Kolmogorov-Smirnov test to assess whether the distribution of phases was consistent with a uniform distribution, indicating no correlation between phase in the *HES7-Achilles* expression and cell division. To this end, we used the *makedist* Matlab function to create a uniform distribution and used the *kstest* Matlab function to compare our sample of phases at cell division with a uniform distribution. This provided a test of hypothesis together with the p-value indicated in the figure legend.

Statistical Analyses {#S24}
--------------------

In box and whiskers plots, middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. Ordinary one-way ANOVA was performed in cases where data was Gaussian and Tukey or Bonferroni correction was used for multiple comparisons. In cases where data was not Gaussian (e.g. phase shifts), we used non-parametric one-way ANOVA with the Kruskal--Wallis test. For time series, such as the Kuramoto order parameter over time, we used paired ANOVA with matched time points. Details of statistical analyses are indicated in figure legends. All differentiation experiments were performed a minimum of three independent times (rounds of differentiation), each containing at least three technical replicates (wells) per condition.

Preparation of single-cell suspensions for single cell RNA-sequencing {#S25}
---------------------------------------------------------------------

Single-cell dissociation protocols for the various tissues and cells analyzed were optimized to achieve \>90% viability and minimize doublets prior to sample collection. For human iPS differentiation, 3x10^4^ *MSGN1-Venus* cells were seeded on Matrigel-coated 24-well plates 48 hours prior to differentiation. Cells were differentiated as described above. All samples (days 1-4 and hiPS control samples) were dissociated, collected and captured on an inDrops setup on the same day, two biological replicates per sample. For dissociation, cells were briefly rinsed in PBS, and incubated in TrypLE Express (Gibco) for 5 min at 37°C. Dissociated cells were run through a 30 μm cell strainer, spun down at 200g for 4 min at 4°C and resuspended in 100 μl 0.5% BSA in PBS.

For mESC differentiation, 1x10^4^ *pMsgn1-Venus* cells were seeded on fibronectin-coated 6-well plates and differentiated as described above. Samples for days 0 and days 2-5 were dissociated in TryplE Express (Gibco) for 3-10 minutes, washed several times in PBS, passed through a 40 μm cell strainer and resuspended in 0.1% BSA in PBS with Opti-Prep at a final density of 200,000 cells/ml. All samples were dissociated, collected and captured on the same day in biological duplicates.

For generating cell suspensions from mouse embryo tailbuds, E9.5 embryos (25-28 somite stage) from CD-1 IGS mice (Charles River) were collected and the posterior part of the embryo, including the last 3 pairs of somites, was carefully dissected from two littermate embryos and subsequently processed as separate samples. Tissues were collected in PBS and dissociated in TrypLE Express for 10 min at 37°C. Cells were rinsed in PBS/EDTA, transferred to 0.5% BSA in PBS, mechanically separated by trituration and run through a 30 μm cell strainer. Cells were spun down at 200 g for 4 min at 4°C and resuspended in 100 μl 0.5% BSA in PBS.

The following number of cells were sequenced per sample: Human iPSC differentiation samples (two biological replicates processed independently)For each replicate hiPS control, 1000 cells; Day 1, 1500 cells; Day 2, 1500 cells; Day 3, 1500 cells; Day 4, 1500 cellsMouse ESC differentiation samplesESC Day 0: 2341 cells. Day 2: 2417 cells. Day 3: Rep. 1 3106 cells, Rep. 2 3189 cells. Day 4: Rep. 1 2939 cells, Rep. 2 2532 cells. Day 5: Rep. 1 1894 cells, Rep. 2 3060 cells.Mouse embryo samples: tailbud cells from two E9.5 embryos (2x 3000 cells processed independently)

Every sample was collected as biological replicate and sequencing data from both samples were combined for data analysis. Actual number of cells captured on inDrops was twice as many as sequenced for backup purposes.

Barcoding, sequencing, and mapping of single-cell transcriptomes {#S26}
----------------------------------------------------------------

Single-cell transcriptomes were barcoded using inDrops^[@R12]^ as previously reported^[@R36]^, using "V3" sequencing adapters. Following within-droplet reverse transcription, emulsions consisting of \~1,000-3,500 cells were broken, frozen at −80C, and prepared as individual RNA-seq libraries. inDrops libraries were sequenced on an Illumina NextSeq 500 using the NextSeq 75 High Output Kits using standard Illumina sequencing primers and 61 cycles for Read1, 14 cycles for Read2, 8 cycles each for IndexRead1 and IndexRead2. Raw sequencing data (i.e. FASTQ files) were processed using the inDrops.py bioinformatics pipeline available at [github.com/indrops/indrops](http://github.com/indrops/indrops). Transcriptome libraries were mapped to human or mouse reference transcriptomes built from the GRCh37 / hg19 (GCF_000001405.13) or GRCm38 / mm10 (GCF_000001635.20) genome assemblies, respectively. Bowtie version 1.1.1 was used with parameter −e 200.

Processing of single-cell RNA-seq data {#S27}
--------------------------------------

Single-cell counts matrices were processed and analyzed using ScanPy^[@R37]^ (1.4.4) and custom Python scripts (see [Code Availability](#S33){ref-type="sec"}). Low complexity cell barcodes, which can arise from droplets that lack a cell but contain backround RNA, were filtered in two ways. First, inDrops data were initially filtered to only include transcript counts originating from abundantly sampled cell barcodes. This determination was performed by inspecting a weighted histogram of Unique Molecular Identifier (UMI) -- gene pair counts for each cell barcode, and manually thresholding to include the largest mode of the distribution (in all cases \>80% of total sequencing reads). Second, low complexity transcriptomes were filtered out by excluding cell barcodes associated with \<250 expressed genes. Transcript UMI counts for each biological sample were then reported as a transcripts x cells table, adjusted by a total-count normalization, log-normalized, and scaled to unit variance and zero mean. Unless otherwise noted, each dataset was subsetted to the 2000 most highly variable genes, as determined by a bin-normalized overdispersion metric. Mouse E9.5 data were filtered for doublet-like cells with Scrublet^[@R38]^, which simulates synthetic doublets from pairs of scRNA-seq profiles and assigns scores based on a k-nearest-neighbor classifier on the PCA-transformed data.

Low Dimensional Embedding and Clustering {#S28}
----------------------------------------

Unless otherwise stated, processed single-cell data were projected into a 50-dimensional principal component analysis (PCA) subspace. The mouse E9.5 PSM (k=20) nearest-neighbor graph used Euclidean distance and 20 PCA dimensions. The mESC and hiPSC neighbor graphs were constructed using the batch-balanced 'bbknn' method^[@R39]^. Clustering was performed using Louvain^[@R40]^ and Leiden^[@R41]^ community detection algorithms.

Identification of Differentially Expressed Genes {#S29}
------------------------------------------------

Transcripts with significant cluster-specific enrichment were identified by a two-sided Wilcoxon rank-sum test comparing cells of each cluster to cells from all other clusters in the same dataset. Genes were considered differentially expressed if they met the following criteria: log fold-change \>0, adjusted p-value \< 0.05. FDR-correction for multiple hypothesis testing was performed as described by Benjamini-Hochberg^[@R42]^. The top 100 differentially expressed genes, ranked by FDR-adjusted p-values, associated fold changes, and sample sizes (number of cells per cluster) are reported in [Table S1](#SD2){ref-type="supplementary-material"}. Gene names for the top 20 differentially expressed transcripts are reported in [Extended Figs. 2D](#F6){ref-type="fig"} (Mouse E9.5), [3C](#F7){ref-type="fig"} (Mouse E9.5 PSM), [3H](#F7){ref-type="fig"} (Mouse ESC), and [3M](#F7){ref-type="fig"} (Human IPSC).

Pseudo-Spatiotemporal Ordering and Identification of Dynamically Varying Genes {#S30}
------------------------------------------------------------------------------

Pseudo-spatiotemporal orderings were constructed by randomly selecting a root cell from the following clusters: 'NMP' (Mouse E9.5 PSM, [Fig. 2c](#F2){ref-type="fig"}); 'd0 ESC' (mESC, [Fig 2d](#F2){ref-type="fig"}); 'd0 iPSC' (hiPSC, [Fig 2f](#F2){ref-type="fig"}) and calculating the diffusion pseudotime (DPT) distance of all remaining cells relative to the root. Trajectories were assembled for paths through specified clusters, with cells ordered by DPT values, as previously reported^[@R43]^. Dynamically variable genes along the Mouse E9.5 PSM trajectory were identified as follows. Briefly, sliding windows of 100 cells were first scanned to identify the two windows with maximum and minimum average expression levels for all genes individually. For each gene, a t-test was then performed between these two sets of 100 expression measurements (FDR \< 0.01). Scaled expression values for significant genes were then smoothened over a sliding window of 100 cells, ranked by peak expression, and plotted as a heatmap [Fig 2c](#F2){ref-type="fig"}. The full list of dynamically expressed genes appears in [Table S2](#SD3){ref-type="supplementary-material"}.

Machine Learning Classification of Cell States {#S31}
----------------------------------------------

Cell state prediction utilized the KNeighborsClassifier, RandomForestClassifier, LinearDiscriminantAnalysis (LDA), and MLPClassifier (NeuralNetwork) classifier methods from scikit-learn (0.20.3). Classifiers were trained on the full Louvain cluster-annotated PCA subspace-projected mouse E9.5 dataset (n=4,367 cells) with default settings and k=20 for KNeighborsClassifier. mESC and hiPSC cell states were predicted after subsetting matching gene symbols for the E9.5 variable gene list, and projecting into the E9.5-defined PCA subspace.

Data Availability {#S32}
-----------------

Raw sequencing data, raw and normalized counts data, and single-cell clustering assignments are available from NCBI Gene Expression Omnibus (GEO), Accession \# GSE114186. Online interactive versions and downloadable versions of the analyzed scRNA-seq datasets, as well as scRNA-seq transcripts x cells counts tables can be accessed at <https://tinyurl.com/DiazPourquie2019> and as follows.

Mouse E9.5 tSNE clustering analysis ([Fig. 2a](#F2){ref-type="fig"} and [Extended Fig. 2c](#F6){ref-type="fig"}):

<https://tinyurl.com/DiazPourquie2019-mE95>

Mouse E9.5 k-nearest neighbor graph of paraxial mesoderm and neural clusters ([Fig 2b](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"} and [Extended Fig 3a](#F7){ref-type="fig"}--[e](#F7){ref-type="fig"}):

<https://tinyurl.com/DiazPourquie2019-mE95-PSM>

Mouse ESC cultures Day 0 -- Day 5 ([Fig 2d](#F2){ref-type="fig"}--[e](#F2){ref-type="fig"}, [Extended Figs. 3f](#F7){ref-type="fig"}--[j](#F7){ref-type="fig"}): <https://tinyurl.com/DiazPourquie2019-mESC>

Human iPSC cultures Day 0 -- Day 4 ([Fig 2f](#F2){ref-type="fig"}--[g](#F2){ref-type="fig"} and [Extended Figs. 3k](#F7){ref-type="fig"}--[o](#F7){ref-type="fig"}):

<https://tinyurl.com/DiazPourquie2019-hIPSC>

Software & Code Availability {#S33}
----------------------------

Single-cell RNA sequencing data were processed and analyzed using publicly available software packages: <https://github.com/indrops/indrops> and <https://github.com/AllonKleinLab/SPRING>. Downstream analysis was performed in ScanPy^[@R37]^ (1.4.3), using Python 3.6.8. Python code and Jupyter notebooks for reproducing single-cell analyses appearing in [Fig 2](#F2){ref-type="fig"} and [Extended Data Figures 2](#F6){ref-type="fig"}--[4](#F8){ref-type="fig"} are available at <https://github.com/wagnerde/Diaz2019>. This Github link also includes detailed instructions for installing necessary python software environment including the following packages and their dependencies: anndata(0.6.22.post1), bbknn(1.3.6), fa2(0.3.5), ipython(7.8.0), jupyterlab(1.1.4), leidenalg(0.7.0), louvain(0.6.1), matplotlib(3.0.3), multicoretsne(0.1), numba(0.45.1), numpy(1.17.2), pandas(0.25.1), pytables(3.5.2), python(3.6.7), python-igraph(0.7.1.post7), scanpy(1.4.4.post1), scikit-learn(0.21.3), scipy(1.3.1), scrublet(0.2.1), seaborn(0.9.0), statsmodels(0.10.1), umap-learn(0.3.10). Force-directed layouts of single-cell graphs were generated using the ForceAtlas2 algorithm in Gephi (0.9.1).

Availability of Materials {#S34}
-------------------------

All materials used in this study, including stem cell lines carrying knock-in reporters, are available by request from the corresponding author.

Extended Data {#S35}
=============

![**a**, Scheme illustrating the maturation stages of paraxial mesoderm. aPSM, anterior PSM; DF, determination front; MPCs, mesodermal precursor cells; pPSM, posterior PSM; NMPs, neuromesodermal progenitors. **b**, Top: Immunofluorescence staining for the cadherins Cdh1 and Cdh2 (top), and the pluripotency factor Pou5f1 (bottom) in differentiating mESCs (left) and hiPSCs (right). n=4 independent experiments. Scale bar = 100 μm. **c**, qRT-PCR for the epiblast marker *Fgf5*, the NMP/mesodermal marker *T/Bra*, and the MPC/PSM markers *Tbx6, Msgn1* and *Rspo3* on days 2-6 of mESC differentiation. Relative expression shown as fold change relative to ESC (day 0). Mean ±SD. n=3 **d**, Percentage induction of the mESC p*Msgn1-Venus* reporter and the hiPSC *MSGN1-Venus* reporter as determined by FACS. Mean ±SD. n=12 (mESC), n=8 (hiPSC) **e**, Gating strategy and representative FACS plots for quantification of *pMsgn1-Venus/MSGN1-Venus* induction. **f**, qRT-PCR for cyclic genes (*HES7, LFNG*), posterior PSM markers (*MSGN1, TBX6, RSPO3*), determination front markers (*MESP2, RIPPLY2*), and anterior PSM markers (*MEST, FOXC2*) on days 1-4 of human iPSC differentiation. Relative expression shown as fold change relative to iPS (day 0). Mean ±SD. n=3 **g**, Diagram outlining the targeting strategy used to generate *Hes7-Achilles/HES7-Achilles* knock-in reporter lines in mouse ESCs and human iPSCs. **h**, Normalized *Hes7-Achilles* fluorescence intensity for three mESC-derived PSM cells imaged in CL medium on day 4 of differentiation. n=4 independent experiments **i**, Representative Fourier transform of *Hes7-Achilles* oscillations in mESC-derived PSM cells indicating the predominant period. n=19 cells **j**, Total time spent in the oscillatory state for *Hes7-Achilles* mESC-derived PSM cells cultured in CL or CLFBR medium from day 4 onwards. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. n=8 (CL), n=12 (CLFBR) **k**, qRT-PCR comparing relative expression levels of *Msgn1, Lfng, T/Bra and Tbx6* in mESC-derived PSM cells cultured in CL or CLFBR medium from day 4 onwards. Relative expression shown as fold change relative to ESC (day 0). Mean ± SD. n=3 **l**, Snapshots of *HES7-Achilles* fluorescence in human iPSC-derived PSM cells showing peaks and troughs over the course of 13.5 hours in CL medium on day 2 of differentiation. n=25 independent experiments. Scale bar = 100μm **m**, Representative quantification of *HES7-Achilles* fluorescence intensity in a small region of interest from day 2 to day 3 of human iPSC differentiation. n=25 independent experiments **n,** Representative Fourier transform of *HES7-Achilles* oscillations indicating the predominant period in day 2 human iPSC-derived PSM cells in CL medium. n=25 independent experiments **o,** Representative instantaneous frequency in Hertz (calculated by Hilbert transformation) of *HES7-Achilles* oscillations in human iPSC-derived PSM cells from day 2 to day 3 of differentiation in CL medium. n=25 independent experiments **p**, Representative instantaneous frequency in Hertz (calculated by Hilbert transformation) of *HES7-Achilles* oscillations in human iPSC-derived PSM cells from day 2 to day 3 of differentiation in CLFBR medium. n=33 independent experiments **q**, Quantification of *HES7-Achilles* fluorescence in human iPSCs differentiated for 48 hours without the BMP inhibitor LDN93189 (CHIR99021 only medium). n=3 independent experiments **r**, Total number of HES7-Achilles oscillations for human iPSC-derived PSM cells cultured in CL or CLFBR medium from day 2 onwards. Mean ±SD. n=15 **s**, qRT-PCR comparing relative expression levels of *HES7, LFNG, TBX6 and MSGN1* in human iPSC-derived PSM cells cultured in CL or CLFBR medium from day 2 onwards. Relative expression shown as fold change relative to iPS (day 0). Mean ± SD. n=3](nihms-1541895-f0005){#F5}

![**a,** Pre-filtering of doublet-like cells. UMAP embedding shows all original E9.5 cells (n=5,646), colored by doublet score. Doublet scores indicate the extent to which a given single-cell transcriptome resembles a linear combination of two randomly selected cells (see [@R38] and [Methods](#S1){ref-type="sec"}). **b,** Histogram of doublet scores. Scores \>0.24 were filtered from subsequent analyses. **c,** tSNE embedding of E9.5 cells (n=4,367) post-doublet filtering. Individual cells are colored according to annotated Louvain cluster IDs. **d,** Top 20 positively enriched transcripts for each Louvain cluster relative to all other clusters, as detected by a two-sided Wilcoxon rank-sum test. Reported transcripts are ranked by FDR-corrected p-values (Benjamini-Hochberg). For exact sample sizes, see [Extended Data Table 1](#T1){ref-type="table"}.](nihms-1541895-f0006){#F6}

![**a,f,k,** ForceAtlas2 layouts of mouse E9.5 embryos, mESC, and hiPSC single-cell kNN graphs, colored by cluster ID and collection timepoints as indicated. **b,g,l,** Confusion matrix plots overlap of cluster and timepoint assignments, row normalized. **c,h,m,** Top 20 positively enriched transcripts for Louvain clusters relative to all other clusters in each dataset, as detected by a two-sided Wilcoxon rank-sum test. Reported transcripts are ranked by FDR-corrected p-values (Benjamini-Hochberg). For exact sample sizes, see [Extended Data Table 1](#T1){ref-type="table"}. **d,i,n,** ForceAtlas2 layouts of single-cell kNN graphs, overlaid with log-normalized transcript counts for indicated genes. **e,j,o,** Top, colors indicate pseudo-temporal orderings. Bottom, heatmap of selected markers of paraxial mesoderm differentiation. Approximate locations of cluster centers are indicated.](nihms-1541895-f0007){#F7}

![**a,c,** ForceAtlas2 layouts of indicated single-cell kNN graphs, overlaid with classifier prediction scores. **b,d,** Heatmap of single-cell HOX gene expression levels for mESC and hiPSC datasets. Columns (individual cells) are grouped by collection timepoint. Rows are individual HOX genes ordered by position. Approximate anatomical positions of HOX paralogs are indicated at right.](nihms-1541895-f0008){#F8}

![**a**, Scheme showing the insertion of a constitutively expressed *pCAG-H2B-mCherry* nuclear label in the safe harbor *AAVS1* locus in a *HES7-Achilles* human iPSC background. **b**, Diffusion (μm^2^/min) for individual human *HES7-Achilles* cells automatically tracked over a period of 24 hours. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. n=76 **c**, Distribution of pairwise instantaneous phase shifts between individual oscillating human *HES7-Achilles* cells, binned by instantaneous distance between pairs of cells. P-values for the pair-wise Kolmogorov-Smirnov test are as follows: 0.6407, 0.1811, 0.1340, 0.1428, 0.6784, 0.8171. n=1000. **d**, Distribution of phases along the unit circle at early, middle, and late timepoints. Each dot represents one cell. n=144 cells. **e**, Illustration of phase determination: representative raw *HES7-Achilles* fluorescence profile for an automatically tracked cell (left) and corresponding processed signal along with the inferred phase from Hilbert transform (right). **f**, Heatmap of *HES7-Achilles* fluorescence intensity over time in automatically tracked cells. Each line represents one cell. n=144 cells. **g**, Histogram of the time (hours since the onset of imaging) at cell division for manually tracked human *HES7-Achilles* cells. n=67 **h**, Left: Immunofluorescence staining for phosphorylated histone H3 (Ser10) in human iPSC-derived PSM cells treated with either vehicle control (DMSO) or 5μM Aphidicolin for 24 or 48 hours, starting on day 2 of differentiation. n=5. Scale bar = 100μm. Right: Quantification of phosphorylated histone H3 (Ser10) nuclei as a percent of total nuclei. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. **i**, Scatter plot showing the cell cycle time in human iPSC-derived PSM cells cultured in CLFBR medium. Mean±SD. n=26. **j**, Scatter plot showing the cell cycle time in human iPSC-derived PSM cells cultured in CLFBR medium. Mean±SD. n=26. **k**, Normalized *HES7-Achilles* fluorescence intensity profiles for 3 individual human iPSC-derived PSM cells pre-treated with 5μM Aphidicolin for 24 hours. n=6 independent experiments. **l**, Kuramoto order parameter over 20 hours on day 3 of differentiation for human *HES7-Achilles* cells treated with vehicle control (DMSO) or 5μM Aphidicolin for 24 hours. Synchronization threshold is shown as the mean±SD of the Kuramoto order parameter for same dataset, but with randomized phases. n=45 cells (Control), 48 cells (Aphi). **m**, Comparison of the Kuramoto order parameter for oscillating *HES7-Achilles* treated with vehicle control (DMSO) or 5μM Aphidicolin. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. Paired two-sided t-test p=0.348. n=45 cells (Control), 48 cells (Aphi). **n**, qRT-PCR for Notch target genes *HES7, NRARP* and *LFNG* in human iPSC-derived PSM cells treated with vehicle control (DMSO) or 25μM DAPT on day 2 of differentiation. Mean±SD. n=3. **o**, Example of *HES7-Achilles* fluorescence intensity in a small region of interest (ROI) over a period of 45 hours in cells treated with DMSO (vehicle control) or the γ-secretase inhibitor DAPT (25μM) in CLFBR medium. n=16 independent experiments **p**, Representative example of *Hes7-Achilles* fluorescence intensity profiles for mESC-derived PSM cells treated with vehicle control (DMSO) or 25μM DAPT. n=13 independent experiments **q**, Kuramoto order parameter over 20 hours on day 2 of differentiation for human *HES7-Achilles* cells treated with vehicle control (DMSO) or 25μM DAPT. Synchronization threshold is shown as the mean±SD of the Kuramoto order parameter for same dataset, but with randomized phases. n=131 cells (Control), 110 cells (DAPT). **r**, Representative immunofluorescence staining for YAP, F-actin (phalloidin) and DAPI nuclear stain in isolated human PSM-like cells treated with either DMSO or Latrunculin A (350nM). Scale bar = 50 μm. n=4 independent experiments. **s**, ChIP-qPCR fold enrichment of the *LFNG* and *HES7* promoters in chromatin pulled down with an antibody against NOTCH1 relative to isotype IgG controls. Mean ±SD. iPSC control n=4, all other conditions n=3. **t**, Mean *HES7-Achilles* fluorescence intensity for isolated human cells cultured with either 350nM Latrunculin A alone or in combination with 25μM DAPT. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. n=18 cells. **u**, Scatter plot showing the *HES7-Achilles* oscillatory period for isolated human cells cultured with either 350nM Latrunculin A alone or in combination with 25μM DAPT. Mean ±SD. n= 47 (LatA), 22 (LatA + DAPT) **v**, Kuramoto order parameter over 18 hours on day 2 of differentiation for human *HES7-Achilles* cells treated with DMSO, LatA alone or LatA in combination with DAPT. Synchronization threshold is shown as the mean±SD of the Kuramoto order parameter for same dataset, but with randomized phases. n=53 cells (Control), 18 cells (LatA), 18 cells (LatA + DAPT). **w**, Comparison of the Kuramoto order parameter in confluent *HES7-Achilles* cells vs. isolated cells treated with either 350nM Latrunculin A alone or in combination with 25μM DAPT. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. Paired one-way ANOVA with Bonferroni correction: Confluent control vs. LatA p=1.16e^−6^, Confluent control vs. LatA + DAPT p=6.8e^−13^, LatA vs. LatA + DAPT p=0.304. n=53 cells (Control), 18 cells (LatA), 18 cells (LatA + DAPT).](nihms-1541895-f0009){#F9}

![**a**, Immunofluorescence staining for doubly phosphorylated ERK on Day 2 of differentiation following 3 hours of treatment with either DMSO (vehicle control) or the FGFR inhibitor PD173074 (250 nM). n=4 independent experiments **b,** Left: qRT-PCR for the FGF ligands *FGF17* and *FGF8* on days 1-4 of human iPSC differentiation. Relative expression shown as fold change relative to iPS (day 0). Mean ±SD n=3 Right: qRT-PCR for the FGF ligand *Fgf8* on days 2-6 of mouse ESC differentiation. Relative expression shown as fold change relative to ESC (day 0). Mean ±SD. n=3 **c**, Time-course qRT-PCR for the FGF target gene *SPRY4* in human iPSC-derived PSM cells during the 10 hours immediately following treatment with either vehicle control (DMSO) or 250nM PD03. Relative expression shown as fold change relative to ESC (day 0). Mean ±SD. n=3 **d**, Immunofluorescence staining for doubly phosphorylated ERK in human iPSC-derived PSM (top) or mESC-derived PSM (bottom) cells treated with either DMSO or PD03 (250 nM). n=4. **e**, Immunofluorescence staining for doubly phosphorylated ERK (left), β-catenin and nuclear stain (right) in human iPSC- derived PSM cells treated with vehicle control (DMSO) or 2μM XAV. n=4 independent experiments. Scale bar = 100μm. **f**, Representative examples of *HES7-Achilles* fluorescence intensity over the course of 45 hours in a small area of interest within human cultures treated with DMSO (vehicle control), the MAPK inhibitor PD0325901 (250nM), or the FGFR inhibitor PD173074 (250nM) in CLFBR medium. n=16 independent experiments. **g**, *HES7-Achilles* fluorescence intensity over the course of 45 hours in a small area of interest within human cultures treated with DMSO (vehicle control), 2μM XAV or 12μM IWR-1 in CLFBR medium. n=3 independent experiments. **h**, *HES7-Achilles* oscillatory period of individual cells treated with vehicle control (DMSO), 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03 on day 2 of differentiation. Mean±SD. One-way ANOVA p values (ns): 0.9929, 0.4097, 0.9998, 0.9845, 0.7425. n=27 (XAV), n=48 (100nM PD03), n=57 (all others). **i**, Average fluorescence intensity profiles for automatically tracked individual *HES7-Achilles* human cells treated with vehicle control (DMSO) or increasing doses of PD03 (100nM, 250nM, 500nM) on day 2 of differentiation. Mean ± 95% CI. n=68 cells (Control), 45 cells (100nM), 35 cells (250nM), 36 cells (500nM). **j**, Representative examples of *HES7-Achilles* fluorescence intensity profiles in a small area of interest within human cultures treated with increasing doses of PD03 (100nM, 250 nM, 500nM) or vehicle control (DMSO). n=8 independent experiments. **k**, Number of *HES7-Achilles* oscillations before arrest in small areas of interest within cultures treated with increasing doses of PD03 (100nM, 250 nM, 500nM). One-way ANOVA:100nM vs. 250nM p=0.0042, 100nM vs. 500nM p=2.0e^−5^. n=6. **l**, Average *HES7-Achilles* fluorescence intensity over the course of the oscillatory regime (i.e. prior to the arrest of oscillations) in cells treated with either vehicle control (DMSO) or increasing doses of PD03 (100nM, 250 nM, 500nM). Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. One-way ANOVA: control vs. 100nM p= 6.7e^−17^, control vs. 250nM p=6.5e^−21^, control vs. 500nM p=1.9e^−22^, 100nM vs. 250nM p=1.1e^−17^, 100nM vs. 500nM p=2.5e^−18^. n=6 **m**, Representative *Hes7-Achilles* fluorescence intensity profiles for mESC-derived PSM cells treated with either vehicle control (DMSO), 2μM XAV or 100nM/250nM/500nM PD03. n=12 (control, XAV, 100nM PD03), n=10 (250nM, 500nM PD03). **n**, Histograms showing the instantaneous phase difference relative to control for individual cells treated with vehicle control (DMSO), 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03. See "[Phase shifts](#S22){ref-type="sec"}" in [methods](#S1){ref-type="sec"} section for details. n fixed at 11,000 observations. **o**, Quantification of the average phase difference (degrees) for *HES7-Achilles* oscillations in cells treated with 250nM PD17 or 100nM/250nM/500nM PD03 relative to control (DMSO) cells. Middle hinge corresponds to median, lower and upper hinges correspond to 1^st^ and 3^rd^ quartiles, lower and upper whiskers correspond to minimum and maximum. n=13 (PD17), n=17 (100nM), n=7 (250nM), n=11 (500nM). **p-q,** Timelapse qRT-PCR for the cyclic genes *HES7* (p) and *LFNG* (q) in human iPSC-derived PSM cells under control (DMSO) and 250nM PD03 conditions. Samples were taken every 30 minutes immediately following treatment. Relative expression shown as fold change relative to ESC (day 0). Mean ±SD. n=3. **r**, Outline of the experimental strategy used to assess the effect of FGF inhibition in primary mouse PSM cells carrying the *LuVeLu* reporter. The tailbud is dissected from E9.5 transgenic embryos and cells are dissociated for seeding on fibronectin micropatterns. Oscillations of the *LuVeLu* reporter are examined in each micropattern. **s**, *LuVeLu* fluorescence intensity profiles in mouse tailbud explant cells cultured on CYTOO micropatterns in CLFBR medium containing DMSO (vehicle control) or increasing doses of PD03 (0.4μM, 0.65μM, 10μM). n=2 independent experiments. **t**, Number of *LuveL*u oscillations before arrest in mouse tailbud explant cells cultured on CYTOO micropatterns treated with DMSO (vehicle control) or increasing doses of PD03 (0.4μM, 0.65μM, 10μM). Mean ±SD. One way ANOVA: 0.4μM vs. 0.65μM p=0.0642, 0.4μM vs. 10μM p=8.4e^−9^, 0.65μM vs. 10μM p=2.9e^−6^. n=10 micropatterns (0.4μM), n=7 micropatterns (0.65μM, 10μM) **u**, Average period of *LuVeLu* oscillations in mouse tailbud explant cells cultured on CYTOO micropatterns treated with DMSO (vehicle control) or increasing doses of PD03 (0.4μM, 0.65μM, 10μM). Mean ±SD. One way ANOVA: control vs. 0.4μM p=0.2785, control vs. 0.65μM p=0.0658, control vs. 10μM p=2.7e^−6^, 0.4μM vs. 0.65μM p=0.831, 0.4μM vs. 10μM p=3.05e^−4^, 0.65μM vs. 10μM p=4e^−3^ . n=18 micropatterns (DMSO), n=16 micropatterns (0.4μM), n=12 micropatterns (0.65μM), n=6 micropatterns (10μM).](nihms-1541895-f0010){#F10}

![**a**, Snapshots of *HES7-Achilles; MESP2-mCherry* double reporter cells on days 2-5 of differentiation in CLFBR medium at 0, 20, 45 and 60 hours. Cultures treated with DMSO (control), 25μM DAPT, 2μM XAV and 250nM PD03 are shown. n=10. Scale bar = 100μm. **b**, Time of *MESP2-mCherry* expression onset in human iPSC-derived PSM cells treated with vehicle control (DMSO), 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03. Expression onset defined by threshold (25 a.u.). Mean ±SD. One-way ANOVA: control vs. XAV p=4.6e^−15^, control vs. 100nM PD03 p=5.1^−17^, control vs. 250nM PD03 p=1.3e^−17^, control vs. 500nM PD03 p= 1.4e^−18^, 100nM vs. 250nM PD03 p=2.6e^−15^, 100nM vs. 500nM PD03 p=7.7e^−16^, 250nM vs. 500nM PD03 p=6.9e^−5^. n=10. **c**, *HES7-Achilles* and *MESP2-mCherry* fluorescence intensity profiles in small regions of interest within human iPSC-derived PSM cultures treated with 25μM DAPT on days 2-5 of differentiation in CLFBR medium. Mean ±SD. Dotted line denotes threshold for *MESP2* activation (25 a.u.). n=15. **d**, qRT-PCR for the genes *HES7, LFNG, MSGN1, TBX6, DUSP6, FOXC2, MESP2* and *RIPPLY2* in human iPSC-derived PSM cultures treated for 24 hours with either vehicle control (DMSO) or 250nM PD03 in CLFBR medium. Relative expression shown as fold change relative to iPS (day 0). Mean ± SD. n=3 **e**, Immunofluorescence staining for TBX6 on day 3 of differentiation (CLFBR medium) in cells treated with either DMSO or PD03 (250 nM). n=4 independent experiments. Scale bar = 100μm.](nihms-1541895-f0011){#F11}

###### 

sgRNAs used in CRISPR/Cas9 targeting

  Target Gene   Direction   sgRNA                  PAM site   PAM site mutation in targeting vector
  ------------- ----------- ---------------------- ---------- ---------------------------------------
  *hHES7*       Antisense   ACCTGCTCGCCCGGACGCCC   GGG        GGT
  *mHes7*       Antisense   TAAGGAGGCACCCAAGCTAC   AGG        AAG
  *hMESP2*      Antisense   GTCTCCAAAACGCGGGCGGT   GGG        GGT

###### 

Primary Antibodies for Immunofluorescence

  Antibody              Species   Type         Source           Catalog Number   Dilution
  --------------------- --------- ------------ ---------------- ---------------- ----------
  OCT3/4                Mouse     Monoclonal   Santa Cruz       Sc-5279          1:800
  SOX2                  Rabbit    Polyclonal   Millipore        AB5603           1:300
  T/BRACHYURY           Goat      Polyclonal   R&D              AF2085           1:300
  TBX6                  Rabbit    Polyclonal   Abeam            ab38883          1:300
  CDH1                  Mouse     Monoclonal   Abeam            ab76055          1:300
  CDH2                  Rabbit    Polyclonal   Abeam            ab12221          1:300
  dpERK                 Rabbit    Monoclonal   Cell Signaling   4370P            1:400
  β-CATENIN             Mouse     Monoclonal   BD               610153           1:400
  YAP                   Mouse     Monoclonal   Santa Cruz       sc-101199        1:200
  pHistone H3 (Ser10)   Rabbit    Polyclonal   Santa Cruz       sc-8656          1:350

###### 

Primer sequences for qPCR

  Gene               Forward                    Reverse                    Reference
  ------------------ -------------------------- -------------------------- ---------------
  *hTBX6*            AAGTACCAACCCCGCATACA       TAGGCTGTCACGGAGATGAA       Loh *et al.*
  *hMSGN1*           CTGGGACTGGAAGGACAGG        ACAGCTGGACAGGGAGAAGA       This study
  *hHES7*            CTCCCTTGCGTCTAGGATTG       CTGAGGGTGGGAGACAGAAG       This study
  *hLFNG*            CTGCTTGGAGGAAGGATTTG       TTGTGGTCAGCAGGAAGAGA       This study
  *hAXIN2*           GGAGTGCGTTCATGGTTTCT       TGCATGTGTCAATGGTAGGG       This study
  *hFGF8*            TCATCCGGACCTACCAACTC       CTCGGACTCGAACTCTGCTT       This study
  *hFGF17*           GAAAGGTCAGCGACTGAAGG       TCTAGCCAGGAGGAGTTTGG       This study
  *hMESP2*           AGCTTGGGTGCCTCCTTATT       TGCTTCCCTGAAAGACATCA       Loh *et al.*
  *HRIPPLY2*         AAGAAGAGGAGACGCCGAAC       AGTCTGACTGGGTGCCTGAA       This study
  *HFOXC2*           CCTCCTGGTATCTCAACCACA1     GAGGGTCGAGTTCTCAATCCC      Loh *et al.*
  *hDUSP6*           CCAAATCATGGGCTCACTTT       CCATGCTCACACACACACAC       This study
  *hSPRY2*           CTGTTTGCGGTGAAATGCT        TTGCCTAGGAGTGTCTGTGTTG     This study
  *hNRARP*           CCTGCGTCACTTTCTGTCCT       AAGGGTCAGCAGCACTTCC        This study
  *hHES7 promoter*   AGATTGTAAGAGGTTGAGGCGGAC   GGAAGGATGACTTGGCGCTC       This study
  *hLFNG promoter*   AGGCTCTGGCTGATCGGAAG       AGGTAATTAGCAGTCACCACCTCC   This study
  *mFgf5*            CTGTACTGCAGAGTGGGCATCGG    GACTTCTGCGAGGCTGCGACAGG    Zhou *et al.*
  *mT/Bra*           GCTTCAAGGAGCTAACTAACGAG    CCAGCAAGAAAGAGTACATGGC     This study
  *mTbx6*            ATGTACCATCCACGAGAGTTGT     GGTAGCGGTAACCCTCTGTC       Chal *et al.*
  *mMsgn1*           CGGCTTAGTCGAGCTGGATTA      CTCCGCTGGACAGACATCTTG      Chal *et al.*
  *mRspo3*           ATGCACTTGCGACTGATTTCT      CAGCCTTGACTGACATTAGGATG    This study
  *mFgf8*            CATGGCAGAAGACGGAGAC        CATGCAGATGTAGAGACCTGTC     Du *et al.*
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**DATA AVAILABILITY STATEMENT** High-throughput sequencing data generated in this study have been deposited to GEO (Accession Number GSE114186.) and can be visualized at <https://tinyurl.com/DiazPourquie2019>. Source data corresponding to the following figure panels are available within the paper and its supplementary information files: [Fig. 1b](#F1){ref-type="fig"}--[f](#F1){ref-type="fig"}, [Fig, 2a](#F2){ref-type="fig"}--[h](#F3){ref-type="fig"}, [Fig. 3a](#F3){ref-type="fig"}--[d](#F3){ref-type="fig"}, [f](#F3){ref-type="fig"}, [h](#F3){ref-type="fig"}, [Fig. 4b](#F4){ref-type="fig"}--[I](#F4){ref-type="fig"}, [Extended data Fig. 1 c](#F5){ref-type="fig"}--[d](#F5){ref-type="fig"}, [f](#F5){ref-type="fig"}--[k](#F5){ref-type="fig"}, [m](#F5){ref-type="fig"}--[s](#F5){ref-type="fig"}, [Extended data Fig. 2 a](#F6){ref-type="fig"}--[c](#F6){ref-type="fig"}, [Extended data Fig. 3a](#F7){ref-type="fig"}--[b](#F7){ref-type="fig"}, [d](#F7){ref-type="fig"}--[g](#F7){ref-type="fig"}, [i](#F7){ref-type="fig"}--[l](#F7){ref-type="fig"}, [n](#F7){ref-type="fig"}--[o](#F7){ref-type="fig"}, [Extended data Fig. 4a](#F8){ref-type="fig"}--[d](#F8){ref-type="fig"}, [Extended data Fig. 5 b](#F9){ref-type="fig"}--[c](#F9){ref-type="fig"}, [g](#F9){ref-type="fig"}--[w](#F9){ref-type="fig"}, [Extended data Fig. 6 b](#F10){ref-type="fig"}--[c](#F10){ref-type="fig"}, [f](#F10){ref-type="fig"}--[q](#F10){ref-type="fig"}, [s](#F10){ref-type="fig"}--[u](#F10){ref-type="fig"}, [Extended data Fig. S7 b](#F11){ref-type="fig"}--[d](#F11){ref-type="fig"}. Additional data, such a raw image files, are available from O.P. (<pourquie@genetics.med.harvard.edu>) upon request.

**CODE AVAILABILITY STATEMENT** Single-cell sequencing data were processed and analyzed using publicly available software packages: <https://github.com/indrops/indrops> and <https://github.com/AllonKleinLab/SPRING>. Jupyter notebooks for reproducing panels in [Fig 2](#F2){ref-type="fig"} and [Extended Data Figures 2](#F6){ref-type="fig"}--[4](#F8){ref-type="fig"} can be accessed at: <https://github.com/wagnerde/Diaz2019>. Matlab code used for single cell tracking and synchronization analysis is available at: <https://github.com/jonathan-touboul-brandeis/HumanSegmentationClock>.

![Recapitulation of the mouse and human segmentation clocks *in vitro* by differentiation of pluripotent stem cells towards PSM fate.\
**a**, Immunofluorescence for stage-specific markers (left) and images of the mESC *pMsgn1-Venus/*hiPSC *MSGN1-Venus* reporters (right) in differentiating mouse ESCs and human iPSCs. Scale bar = 100μm. n=7 independent experiments. **b**, Normalized *Hes7-Achilles* intensity profiles for three mESC-derived PSM cells imaged in CLFBR medium. n=17 independent experiments **c**, Period of *Hes7-Achilles/HES7-Achilles* oscillations in mouse ESC-derived PSM and human iPSC-derived PSM cells cultured in CLFBR medium. Mean ±SD. n=25 **d**, Heatmap of *Hes7-Achilles* intensity over time in mESC-derived PSM cells in CLFBR medium. Each row represents one cell. n=15 **e**, Normalized *HES7-Achilles* intensity profiles for three human iPSC-derived PSM cells imaged in CLFBR medium. n= 23 independent experiments **f**, Heatmap of *HES7-Achilles* intensity over time in human iPSC-derived PSM cells in CLFBR medium. Each row represents one cell. n=15](nihms-1541895-f0001){#F1}

![Single cell RNA-sequencing analysis of differentiating mouse and human PSM.\
**a,** Nearest-neighbor (kNN) graph of mouse E9.5 neural tube, PSM, and somite clusters (2,340 cells, 20 PC dimensions), visualized with ForceAtlas2 and colored by Louvain cluster ID. **b,** Pseudo-temporal ordering of non-neural E9.5 cells. Heatmap illustrates genes with significant dynamic expression ordered by peak expression (see [Methods](#S1){ref-type="sec"}) and selected markers of paraxial mesoderm differentiation. Color bars indicate pseudotemporal position and Louvain cluster assignments. Dotted line marks the determination front (boundary between anterior/posterior PSM). **c,** Batched-balanced kNN graph of mouse ESC single-cell transcriptomes (21,478 cells), colored by Louvain cluster ID and visualized with ForceAtlas2. Cell numbers for the three terminal day 4/5 states are indicated. **d,** Pseudo-temporal ordering of mESCs along a path towards the putative d4/5 PSM state. Heatmap shows selected markers of paraxial mesoderm differentiation. **e,** Batched-balanced kNN graph (ForceAtlas2 layout) of hiPSC single-cell transcriptomes (14,750 cells), colored by Louvain cluster ID. **f,** Pseudo-temporal ordering of hiPSCs along a path towards the terminal d3/4 PSM state. Heatmap shows selected markers of paraxial mesoderm differentiation. **g,** Machine-learning classification of human and mouse *in vitro* cultured cells. A kNN-classifier trained on E9.5 clusters was used to predict identities of terminal *in vitro* states (inset, red cells). Heatmaps depict fraction of E9.5 assignments for mESC day 4/5 PSM cells and hiPSC (day 2-4 cells). **h,** Overlay of kNN-classifier scores (fraction of nearest neighbors with the E9.5 'pPSM' label) onto the mESC and hiPSC kNN graphs.](nihms-1541895-f0002){#F2}

![Synchronization of individual oscillators within human PSM cultures.\
**a**, Experimental strategy for automated tracking of *HES7-Achilles* oscillations in individual cells. Scale bar = 100μm **b**, Kuramoto order parameter for *HES7-Achilles* cells vs. the same dataset with randomized phases. Mean ±SD. Paired two-sided t-test p=5e^−107^. n=139 cells. **c**, Kuramoto order parameter timecourse of *HES7-Achilles* human PSM cells. Synchronization threshold shown as mean±SD of the Kuramoto order parameter for same dataset, but with randomized phases. n=139 cells **d**, Average intensity profiles for individual *HES7-Achilles* human PSM cells treated with vehicle control (DMSO) or 25μM DAPT. Mean ± 95% CI. n=152 cells (Control), 106 cells (DAPT). **e**, *HES7-Achilles* fluorescence in human PSM cells following treatment with DMSO or DAPT (25μM). n=9 independent experiments. Scale bar = 100μm **f**, Kuramoto order parameter for *HES7-Achilles* cells treated with DMSO or 25μM DAPT. Mean ±SD. Paired two-sided t-test p=2.6e^−18^. n=131 cells (Control), 110 cells (DAPT). **g**, Experimental strategy for analysis of oscillations in isolated human PSM cells. **h**, Representative *HES7-Achilles* intensity profiles for three isolated human PSM cells in medium containing DMSO, 350nM LatA, or 350nM LatA in combination with 25μM DAPT. n=5 independent experiments.](nihms-1541895-f0003){#F3}

![FGF signaling regulates the dynamic properties of the segmentation clock.\
**a**, Left: Scheme illustrating the posterior-to-anterior gradients of FGF and Wnt signaling along the PSM. Right: Immunofluorescence for doubly phosphorylated ERK, β-catenin and DAPI nuclear stain in differentiating human iPSCs and mouse ESCs. n=8 independent experiments. Scale bar = 100μm. **b**, Average intensity profiles for individual *HES7-Achilles* human PSM cells treated with vehicle control (DMSO), 250nM PD03 or 250nM PD17. Mean ± 95% CI. n=89 cells (Control), 30 cells (PD03), 34 cells (PD17) **c**, Average intensity profiles for individual *HES7-Achilles* human PSM cells treated with vehicle control (DMSO) or 2μM XAV. Mean ± 95% CI. n=67 cells (Control), 29 cells (XAV). **d**, Number of *HES7-Achilles* oscillations before arrest in individual human PSM cells treated with 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03. Mean ±SD. One-way ANOVA:100nM vs. 250nM p=2.3e^−5^, 100nM vs. 500nM p=2.2e^−10^, 250nM vs. 500nM p=1.5e^−3^. n=34 **e**, Mean *HES7-Achilles* intensity for individual *HES7-Achilles* human PSM cells treated with 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03. Mean ±SD. One-way ANOVA: 100nM vs. 250nM p=1.2e^−13^, 100nM vs. 500nM p=3e^−13^, 250nM vs. 500nM p=6.9e^−6^. n=46 (XAV), n=28 (PD17), n=47 (100nM PD03), n=64 (250nM PD03), n=26 (500nM PD03). **f**, Summary statistics comparing the instantaneous absolute phase difference relative to control for individual cells treated with vehicle control (DMSO), 2μM XAV, 250nM PD17 or 100nM/250nM/500nM PD03. Mean ±SD. One-way ANOVA: control vs. XAV p= 0.0578, control vs. PD17 p=9.^2e-8^, control vs. 100nM PD03 p=1.^3e-14^, control vs. 250nM PD03 p=1.1e^−8^, control vs. 500nM PD03 p=1.1e^−5^, 100nM vs. 250nM PD03 p=0.8338, 100nM vs. 500nM PD03 p=0.0601, 250nM vs. 500nM p=0.061. n fixed at 11,000 observations. See [Extended data Fig. 6n](#F10){ref-type="fig"} for full histograms. **g-i**, *HES7-Achilles* and *MESP2-mCherry* intensity profiles in small regions of interest within human PSM cultures. Mean ±SD. Dotted line denotes threshold for *MESP2* activation (25 a.u.). g, Vehicle control (DMSO) h, 250nM PD03 i, 2μM XAV. n=15.](nihms-1541895-f0004){#F4}
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